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1 REVIEW OF THE LITERATURE 
1.1  CYANOBACTERIA IN THE ENVIRONMENT 
Cyanobacteria are ancient organisms dating back as far as 3.5 billion years (Schopf, 1993). The 
phylum Cyanobacteria is a diverse group of photosynthetic gram-negative bacteria responsible for 
creating the oxygenic atmosphere on earth (Blank and Sánchez-Baracaldo, 2010). Morphology, 
physiology and habitat differ between species, and enable the cyanobacteria to adapt and colonize 
a great variety of different environments. The characterization and classification of cyanobacteria 
is challenging and molecular, morphological, physiological and biochemical data are combined 
(Komárek et al., 2003). The taxonomic category “species” is problematic among cyanobacteria in 
the light of modern classification criteria but traditionally about 2000 species belonging to 150 
genera have been estimated to exist (van den Hoek et al., 1995; Wilmotte and Herdman, 2001). 
1.1.1 Cyanobacterial blooms 
Aquatic cyanobacteria occur in fresh water, brackish water and marine environments. 
Cyanobacteria vary in shape and appearance, single cells being about 1 to 10 µm in diameter or 
length and appearing unicellularly or as colonies of many shapes, or formations of filaments 
(Garcia-Pichel, 2009). One colony may contain hundreds or thousands of cells and grow to 
millimeters in diameter. In favorable environmental conditions cyanobacterial blooms may 
develop. A dense cyanobacterial bloom seriously deteriorates the water quality, also by decreasing 
the oxygen level when decaying. Some cyanobacteria produce slime and odorous compounds that 
can cause problem in the water treatment (Srinivasan and Sorial, 2011). The most serious 
ecological problem and health risk to humans and animals is the production of cyanobacterial 
toxins (Codd et al., 2005). 
A bloom arises when cyanobacteria dominate the freshwater environment. The out-competition of 
other phytoplankton members originates from several distinct properties (Carey et al., 2012). 
Many cyanobacteria can differentiate into particular cell types, like heterocysts that have thick cell 
walls and are able to fix nitrogen. Special resting cells, akinetes, enable cyanobacteria to survive in 
unfavourable conditions and regenerate when conditions improve. Gas vesicles regulate the 
buoyancy of cyanobacteria, allowing them to adopt an optimum depth in the water column. 
Cyanobacteria tolerate low light conditions and for example Planktothrix, is low light adapted and 
can form dense populations in the epilimnion of a lake (Reynolds et al., 1987; Lindholm and 
Meriluoto, 1991).  
1.2 SECONDARY METABOLITES IN CYANOBACTERIA 
Cyanobacteria produce a variety of unique secondary metabolites (Fujii et al., 2000; Welker et al., 
2006; Van Wagoner et al., 2007). Several of these are small but complex alkaloids or peptides 
whose true function has not yet been elucidated (Harada, 2004). Some cyanobacteria produce 
toxins as secondary metabolites and they deserve attention due to their impact on human society 
and the environment (Codd et al., 2005; Wiegand and Pflugmacher, 2005). The cyanotoxins are 
both chemically and toxicologically a diverse group of natural toxins (Sivonen and Jones, 1999). 
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Cyanotoxins seem to be more toxic to mammals than to aquatic organisms (Ibelings and Havens, 
2008). According to traditional bacterial systematics at least 46 cyanobacterial species have been 
reported to produce toxins (Sivonen and Jones, 1999).  
1.2.1 Hepatotoxins 
The compounds most often implicated in cyanobacterial toxicosis are hepatotoxins called 
microcystins and nodularins. The large and diverse heptapeptide family of microcystins has been 
the most frequently reported cyanobacterial toxin (more detailed information regarding 
microcystins is found in the section Microcystins and in Risk Assessment for Human Health). 
Microcystins are typically found in species of the freshwater genera Microcystis, Planktothrix, 
Anabaena, Nostoc, Phormidium, Hapalosiphon, Fischerella and Anabaenopsis amongst others 
(Krishnamurthy et al., 1986; Meriluoto et al., 1989; Sivonen et al., 1990; Prinsep et al., 1992; 
Moore, 1996; Izaguirre et al., 2007; Fiore et al., 2009). The smaller and less diverse pentapeptide 
family of nodularins comprises about 10 different variants, produced predominantly by Nodularia 
(Rinehart et al., 1988; Sivonen and Jones, 1999). These closely related peptides are potent protein 
phosphatase inhibitors with a primary effect on hepatocytes (Falconer and Yeung, 1992; Runnegar 
et al., 1993).   
1.2.2 Neurotoxins 
Cyanobacteria produce a variety of heterocyclic alkaloid neurotoxins. The main neurotoxins are 
divided into three groups: a) anatoxin-a and analogues, b) anatoxin-a(S), and c) saxitoxin and 
analogues.  
Anatoxin-a and homoanatoxin-a are bicyclic secondary amines with potent neuromuscular 
blocking effects (Devlin et al., 1977; Carmichael, 1992). Anatoxin-a binds to neuronal nicotinic 
acetylcholine receptors at neuromuscular junctions, acting as a nicotinic (cholinergic) agonist 
(Swanson et al., 1986). LD50 values for anatoxin-a and homoanatoxin-a are 200 – 250 µg/kg body 
weight (Devlin et al., 1977; Carmichael et al., 1990; Skulberg et al., 1992). Cyanobacterial species of 
Anabaena, Aphanizomenon, Cylindrospermum, Microcystis, Oscillatoria and Planktothrix can 
produce anatoxin-a and/or homoanatoxin-a (Sivonen and Jones, 1999).  
Anatoxin-a(S) is an organophosphate that inhibits acetylcholinesterase at the neuromuscular 
junction (Mahmood and Carmichael, 1987). Despite its name it is not chemically related to 
anatoxin-a, but it was isolated from the same species (A. flos-aquae). The LD50 value of anatoxin-
a(S) is approximately 50 µg/kg (mouse, i.p.) (Mahmood and Carmichael, 1986). Some strains of the 
genus Anabaena produce anatoxin-a(S) (Onodera et al., 1997a). 
Saxitoxins, also known as paralytic shellfish poisons (PSP), are a large group of sodium channel 
antagonists. The toxicities of the variants differ significantly with saxitoxin being the most toxic 
one with an LD50 of 10 µg/kg (mouse, i.p.) (Carmichael et al., 1990; Funari and Testai, 2008; 
Humpage, 2008). These toxins are produced by e.g. Anabaena circinalis, Lyngbya wollei and 
Cylindrospermopsis raciborskii, although they were originally isolated from shellfish and marine 
dinoflagellates (Humpage et al., 1994; Onodera et al., 1997b; Lagos et al., 1999). 
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1.2.3 Cytotoxins 
Cylindrospermopsin is a cyclic guanidine alkaloid the main toxic effect of which is to irreversibly 
inhibit protein synthesis (Terao et al., 1994; Runnegar et al., 2002). The acute effect seems to be 
mediated by CYP450 generated metabolites which inhibit the synthesis of glutathione (Runnegar 
et al., 1995b; Norris et al., 2002; Froscio et al., 2003; Humpage et al., 2005 ). Cylindrospermopsin 
has two further structural variants, the toxic 7-epicylindrospermopsin (Banker et al., 2000) and the 
7-deoxycylindrospermopsin, whose level of toxicity is still under debate (Runnegar et al., 2002; 
Neumann et al., 2007). Cylindrospermopsin and its variants are produced by e.g. 
Cylindrospermopsis raciborskii, Aphanizomenon ovalisporum, Raphidiopsis curvata, Anabaena 
lapponica and Lyngbya wollei (Ohtani et al., 1992; Norris et al., 1999; Banker et al., 2000; Li et al., 
2001; Spoof et al., 2006; Seifert et al., 2007). 
1.2.4 Lipopolysaccharides 
Lipopolysaccharides (LPS) are endotoxins found in the outer membrane of several gram-negative 
bacteria including cyanobacteria. The biological activity of LPS is attributed to the detailed 
structure of lipid A (Stewart et al., 2006). No cyanobacterial lipid A structure has so far been 
described or published (Stewart et al., 2006). However, cyanobacterial lipopolysaccharides are 
considered to be less toxic than the LPS of other bacteria like e.g. Salmonella  (Raziuddin et al., 
1983; Rapala et al., 2002; Best et al., 2003) but can give rise to pyrogenic, irritant and allergenic 
responses in humans and animals (Ressom et al., 1994). Some studies claim that the endotoxicity 
of cyanobacterial LPS is comparable to heterotrophic bacteria (Bernardova et al., 2008). Co-
exposure to cyanobacterial lipopolysaccharides and microcystins has been shown to reduce 
microcystin detoxification capabilities in zebra fish (Best et al., 2002). The life history of Daphnia 
galeata was shown to be affected in a context dependent manner by the microcystin-producing 
strain and concentration together with the LPS source (Dionisio Pires et al., 2011).  
1.3 MICROCYSTINS 
Microcystins are not essential for cyanobacterial primary metabolism (Carmichael, 1992; Tillett et 
al., 2000; Christiansen et al., 2003). In healthy growing cyanobacteria most of the microcystins 
reside within the cell (Lam et al., 1995). When cell lysis occurs the cell-bound toxins are released 
into the water (Lam et al., 1995). Cyanobacterial species can simultaneously produce many 
different variants of microcystins (Rantala et al., 2006). Both changes in the environment and 
genetic factors lead to variations in the production and composition of microcystins (Sivonen, 
2009; Jähnichen et al., 2011).  
1.3.1 Structure and nomenclature 
Microcystins are cyclic heptapeptides with the following structure: cyclo(-D-Ala1-X2-D-MeAsp3(iso-
linkage)-Z4-Adda5-D-Glu6(iso-linkage)-Mdha7), where MeAsp is erythro-β-methylaspartate and 
Mdha is N-methyldehydroalanine (Carmichael et al., 1988; Rinehart et al., 1994). The structure was 
elucidated by Botes et al. (Botes et al., 1984; Botes et al., 1985) and Rinehart et al. (Rinehart et al., 
1988). The β-amino acid Adda, (2S,3S,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-
4E,6E-dienoic acid, is an uncommon and unique amino acid found in microcystins and nodularins 
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(Botes et al., 1984; Botes et al., 1985; Rinehart et al., 1988). Microcystin variants are named after 
their structure by using the single letter code of amino acids. The most frequently found 
microcystin is microcystin-LR, abbreviated to MC-LR (Fig 1). Substitution of the L-amino acids at 
position 2 (X) and 4 (Z) and the demethylation of the amino acids at position 3 (MeAsp) and/or 7 
(Mdha) are the most common variations in the structure. However, all of the amino acids can vary 
(Sivonen and Jones 1999). At the moment over 100 different microcystin variants are described in 
the literature (partially reported in Sivonen and Jones, 1999; Brittain et al., 2000; Matthiensen et 
al., 2000; Sano et al., 2004; Spoof, 2004). New structural variants within the microcystin family are 
reported continuously.  
NH
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Figure 1. Structure of microcystin-LR, the most frequently encountered microcystin. 
1.3.2 Physicochemical properties 
Microcystins are chemically stable molecules, not particularly sensitive to hydrolysis, oxidation or 
heating (Harada, 1996). Microcystins are not destroyed by boiling (Metcalf and Codd, 2000). 
Chlorination, ozonation and reverse osmosis treatments are effective procedures in water works 
to remove microcystins (Tsuji et al., 1997; Hitzfeld et al., 2000; Liu et al., 2010). In natural 
environments, microbial decomposition of microcystins is usually slow, often requiring an 
extended lag time (Lahti et al., 1997; Holst et al., 2003). Dissolved microcystins can be degraded by 
photodegradation, and the rate is accelerated when cyanobacterial pigments are present (Tsuji et 
al., 1994; Wörmer et al., 2010). The distribution ratio of microcystin-LR in octanol/water (log Dow) 
was shown to vary between 2.18 and -1.76, depending on the pH (de Maagd et al., 1999). The low 
log Dow at higher pH values suggested a low tendency of MC-LR to bioconcentrate from water to 
biota (de Maagd et al., 1999). The 1-octanol/water partition coefficients (log P) of MC-LW and -LF 
have been estimated to be 3.46 and 3.56, respectively (Ward and Codd, 1999). 
The arrangement of amino acid residues in small peptides is crucial to the overall hydrophobicity 
of the molecule (Liu et al., 2005). Microcystins are amphipathic molecules with hydrophobic 
groups in combination with polar groups of hydrophilic character. The amino acid Adda gives a 
certain degree of hydrophobicity to the rather hydrophilic molecule. All seven amino acids that 
compose the microcystin molecule contribute to the properties, physicochemical as well as toxicity 
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and protein phosphatase inhibition capacity, of the different variants (Stotts et al., 1993). In Table 
1 a few common variants of microcystins are listed along with their molecular weight and toxicity 
data. Certain parts of the molecular structure are crucial for MC-LR to retain toxicity, e.g. the cyclic 
structure (Choi et al., 1993), the trans-isomeric structure at C-6 in the Adda double bond (Harada 
et al., 1990) and the non-esterified carboxy group in the glutamate position 6 (Rinehart et al., 
1994) since modification at these positions resulted in non-toxic microcystins.  
Table 1. Molecular weights and toxicity data (LD50, µg/kg, mouse, i.p.) for some  
common microcystin variants. Table modified from Sivonen & Jones 1999. 
 
 
 
 
 
 
 
 
 
 
 
1.3.3 Interaction with membranes 
There are numerous bioactive peptides, among them microcystins, that need to be taken up by 
transport proteins or penetrate the cell membrane in order to elicit their action. The ability of a 
compound to interact with biological membranes might influence the compound’s biological 
activity, as well as pharmacological parameters like absorption, biotransformation, half-life and 
excretion of the compound (de Matos Alves Pinto et al., 2006). Small molecules that interact with 
lipids, or proteins, in the membrane or at the membrane interface, affect the properties of the 
membrane (MacCallum et al., 2008). Although the effect of a compound is initially subtle and local, 
the consequence of the interaction might be amplified and spread throughout the whole 
membrane surface and volume (Bagatolli and Gratton, 2000; Garcia and Perillo, 2002). Compounds 
can have different effects on a membrane. Some peptides, or aggregates of peptides, are able to 
form e.g. inclusions within the membrane and influence the bilateral pressure profile of lipids 
(Cantor, 2002). E.g. magainin-2 can form small, transient openings in the membrane and 
ceratotoxins a transmembrane channel (Bessin et al., 2004; Burkhard, 2005; Bechinger and Lohner, 
2006). Some molecules, e.g. filipin, have been shown to specifically interact with certain sterols or 
proteins in, or associated to, cell membranes (Loura et al., 2001). Amphiphilicity is an important 
feature of peptides able to absorb to or disrupt membranes (Strömstedt et al., 2010). E.g. melittin, 
a thoroughly studied peptide from bee venom, is efficient in lysing biological membranes (Hristova 
et al., 2001). Membrane effects of microcystins have not been studied thoroughly although MC-LR 
has been shown to induce membrane instability (Hermansky and Stohs, 1991; Sicinska et al., 
Microcystin MW Toxicity LD50 
(µg/kg, mouse, i.p.) 
MC-LR 994 50 
MC-LA 909 50 
MC-YR 1044 70 
MC-LY 1001 90 
[D-Asp3]-MCLR 980 160-300 
[Dha7]-MC-RR 1023 180 
[Dha7]-MCLR 980 250 
[D-Asp3]-MCRR 1023 250 
MC-RR 1037 320-600 
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2006). Theoretically, the hydrophobic properties of microcystins could enhance their penetration 
capacity across cell membranes.  
Interactions of small molecules with biological membranes are difficult to study due to the 
complexity and heterogeneity of the membrane (Lee, 2011). Biological membranes are composed 
of a mixture of lipids organized as a bilayer matrix and associated with different kinds of proteins. 
The lipid molecules in bilayer membranes are orientated so that their polar head groups are faced 
towards the bulk water and the non-polar acyl chains are directed towards each other (Fig.2). 
Conclusions on how small molecules possibly interact with intact biological membranes can be 
drawn by using different kinds of membrane models with defined lipid compositions (Papo and 
Shai, 2003). The study of properties and interactions with monolayers is of direct significance to 
bilayers and consequently to biological membranes (Brezesinski and Möhwald, 2003). 
Monomolecular layers are simple model membranes that can be established at an air-water 
interface (Jones and Chapman, 1995). By combining a relatively large hydrophobic group with a 
polar or charged headgroup a layer, one molecule thick, can be formed at the aqueous-air 
interface. The hydrophilic nature of the polar headgroup anchors the molecule to the aqueous 
interface and allows the hydrophobic group to protrude towards the air phase (Fig. 2).  
 
Figure 2. A lipid monolayer (A), a lipid bilayer with the hydrophobic fatty acid chains protruding 
towards each other (B), and a unilamellar vesicle enclosing an aqueous compartment (C). 
Monolayers as well as bilayers exist in different phase states, depending on temperature and 
pressure (Brockman, 1999). The interfacial surface density of molecules in the monolayer is 
controlled by the amount of amphiphile placed on the interface and the area available to it (Jones 
and Chapman, 1995). When compressing a monolayer, the area per molecule at the interface is 
reduced, and a number of phases can be clearly identified. The gaseous phase (G), liquid expanded 
phase (LE), liquid-condensed phase (LC) and finally the solid (S) phase are recognized (Fig. 3). In 
between, mixtures of two different phases can be seen. From the gas phase to the solid phase the 
headgroup separation is decreasing, the order is increasing and the conformational freedom of the 
alkyl chains is lost (Jones and Chapman, 1995).  
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Figure 3. Different phases (solid, liquid and gas) that can be identified as a monolayer is 
compressed. Picture drawn by the author inspired by KSV Nima, Espoo, Finland. 
 
1.4 ANALYTICAL METHODS FOR MICROCYSTINS 
The presence of microcystins in drinking water and in food is a matter of concern for human health 
and has led to the development of sensitive analytical methods for detection of microcystins and 
microcystin-producing cyanobacteria (Sivonen, 2008). The World Health Organization has set a 
provisional guideline value of 1 µg microcystin-LR per litre drinking water since microcystins pose a 
threat to human health (WHO, 2011). The occurrence of microcystins is often reported as 
microcystin-LR equivalents, despite which variants are present in the sample. When choosing 
which analytical method to use e.g. cost, time, sensitivity and specificity need to be considered.  
From an analytical point of view the structural diversity among microcystins constitutes a 
demanding task. Several microcystin variants usually exist in a sample and different microcystins 
have different toxicity (Vasconcelos et al., 1996; Sivonen and Jones, 1999). A natural bloom 
contains several cyanobacterial species (Stal et al., 2003). Within a species, like Microcystis 
aeruginosa, there are non-toxic, toxic and highly toxic strains. A highly toxic strain can produce 
several microcystins, e.g. eleven different variants (Krüger et al., 2010).  
1.4.1 High-performance liquid chromatography 
High-performance liquid chromatography (HPLC) is a reliable and widely accepted 
chromatographic technique used in detection of microcystins (Lawton et al., 1994; Meriluoto, 
1997). Microcystins in a sample can be separated in order to be identified, quantified or purified 
(Meriluoto, 1997; Lawton and Edwards, 2001). Depending on the composition of the stationary 
phase and the composition and gradient of the mobile phase, analytes with e.g. varying polarity 
can be separated in a single run (Mant and Hodges, 2006; Neffling et al., 2009). When separating 
peptides, the mobile phase is often composed of water-acetonitrile gradients in the presence of 
trifluoroacetic acid (Garcia, 2005).  
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A large number of detectors have been developed for liquid chromatography. In common use in 
microcystin analysis is UV absorbance detection with either a variable-wavelength or a diode-array 
detector (Meriluoto, 1997). Several compounds absorb UV light in the range of 200 to 350 nm and 
the intensity of UV light absorbed in the detector cell can be related to analyte concentration using 
Lambert-Beers’ law. A diode-array detector (DAD) detects eluted analytes over a range of 
wavelengths simultaneously and peak spectra can be used for verification of analyte identity. UV 
detection is not specific since almost all microcystins have a UV absorbance maximum at 238 nm, 
together with many other compounds (Nageswara and Nagaraju, 2003). When analysing a 
chromatogram standards are needed since the microcystin variants are identified based on their 
retention times (Meriluoto, 1997). Commercially available standards can be found for some of the 
microcystin variants, such as MC-LR, -RR, -YR, -LA, -LW and -LF. A UV absorbance detector have 
limitations in complex analyses as it lacks specificity and the matrix, coeluting compounds, solvents 
and additives can influence the analyte spectra (Meriluoto, 1997; Williams, 2004). The sample 
needs to be pretreated, often by solid-phase extraction, concentration and filtering of the sample.  
Developments in HPLC aim at improved resolution and selectivity, sharper peak shape and faster 
run times. With HPLC-DAD and liquid chromatography-mass spectrometry (LC-MS) microcystin 
variants can be separated and quantitated (Harada et al., 1996; Meriluoto et al., 2000; Spoof et al., 
2009). In LC-MS for microcystins the sample is separated by liquid chromatography usually on 
narrower columns and online loaded onto the MS instrument (Neffling et al., 2009). In the ion 
source of the mass spectrometer the solvent flow undergoes vaporisation to remove solvent and 
generate gas-phase ions. Electrospray ionisation (ESI) is a technique used for a broad range of 
analytes. A fine aerosol of charged droplets is produced when the sample exits a metal capillary 
kept at a specific potential and is nebulised by nitrogen. The droplets are decreased further until 
repulsion causes the sample ions to be ejected from the droplet surface (ion evaporation). The 
ions are then separated by their mass-to-charge ratio in the mass analyser. The commonly used 
quadrupole mass analyser consists of four parallel metal rods with opposing potentials. When 
applying a radio frequency field, the ions pass according to their mass-to-charge ratio through the 
quadrupole to the detector. In a triple quadrupole MS instrument (LC-MS-MS) there are three 
quadrupoles in a linear series and this allows the study of fragments, or daughter ions (for 
microcystins, see e.g. Neffling et al., 2010). The first quadrupole usually acts as a filter that only 
allows passage of an ion of a specific m/z. The second quadrupole (collision cell) fragments that ion 
further. The third quadrupole scans the fragments produced. Detection of cyanobacterial toxins by 
mass spectrometry makes liquid chromatography (LC-MS) a powerful analytical technique with 
high sensitivity and specificity (Kaya et al., 2001; Barco et al., 2002; Neffling et al., 2009). LC-MS 
can deal with complex samples, trace levels and small sample volumes (Barco et al., 2004; Shan et 
al., 2011).  
1.4.2 Protein phosphatase inhibition assay 
Protein phosphatase inhibition assays (PPIA) for microcystins are based on inhibition of the activity 
of the catalytic subunits of serine/threonine protein phosphatases (PP) type 1 and type 2A 
(MacKintosh et al., 1990; An and Carmichael, 1994). Protein phosphatases dephosphorylate 
proteins, removes a phosphate group (PO3) from a protein (MacKintosh et al., 1990). Many 
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enzymes and receptors are regulated by reversible phosphorylation caused by kinases and 
phosphatases. By inhibiting protein phosphatases the phosphorylation state of several proteins 
within the cell is increased. Microcystins inhibit the activity of PP1 and PP2A in a dose-dependent 
manner (Solter et al., 1998).  Different microcystin variants have different affinities for a specific 
protein phosphatase (Mountfort et al., 2005). Protein phosphatase inhibition is however not 
directly correlated to acute toxicity (Blom and Juttner, 2005). Protein phosphatase inhibition 
assays are sensitive methods, with detection limits like 0.17 µg/l (Sassolas et al., 2011). Lower 
detection limits has also been reached (Ikehara et al., 2008). Although enzyme assays usually are 
highly specific, the protein phosphatase inhibition assay is not exclusively specific for microcystins 
(Honkanen et al., 1994). For example anabaenopeptins, produced by several microcystin-
producing genera, are also protein phosphatase inhibitors (Harada et al., 1995).   
Enzyme assays are used to measure the activity of an enzyme. In assays developed for microcystins 
either PP1 or PP2A are used, and a substrate, e.g. p-nitrophenyl phosphate is added. The 
consumption of the substrate or the development of the product is measured after a time-point or 
continuously during the experiment. Performing the assay in microtiter plates makes it possible to 
analyse several samples at the same time (Ward et al., 1997). Several detection methods are 
available, spectrophotometric, fluorometric, luminometric, and radiometric, among others. 
Enzymes are however prone to easily be inactivated, and attention must be paid to e.g. salt 
concentration, temperature and pH (Silvestre et al., 2011). Moreover, cofactors are sometimes 
necessary, the lifetime of enzymes is limited and interfering factors might exist in the sample 
(Silvestre et al., 2011). 
1.4.3 Immunoassays 
In immunoassays specific polyclonal or monoclonal antibodies (or antibody-like molecules) are 
used for identification and quantification of an analyte, an antigen. Antibodies aimed against 
microcystins are versatile tools for monitoring, detecting and quantifying microcystin-
contaminated water (Campas and Marty, 2007; Long et al., 2009; Xia et al., 2011). Using 
immunoassays, such as ELISA (enzyme-linked immunosorbent assay) or TR-FIA (time-resolved 
fluoroimmunoassay), the concentration of microcystins in natural waters can be determined 
without any need to concentrate the sample (Lei et al., 2004; McElhiney and Lawton, 2005). 
Immunoassays have potential for microcystin analysis since they are easy to use, sensitive and 
specific (Metcalf and Codd, 2003). The functionality of the assays relies on the binding reaction 
between the antibody and the antigen, and the detection method.  
In immunoassays, the interaction between antibody and the antigen is connected to a reaction 
that gives an observable signal. This interaction is dependent on non-covalent bonds, such as 
hydrogen bonding, ion bonding, hydrophobic interaction and van der Waals forces (Deshpande, 
1996). The intensity of the interaction depends on the number of these weak non-covalent bonds.  
In quantitative assays the calibrators consist of a negative sample with no analyte present and 
positive samples having different concentrations of the analyte. The specificity of an immunoassay 
is determined by the cross-reactivity with structurally similar molecules to the analyte (Saito et al., 
1994). Antibodies for microcystins developed so far cross-react with different microcystin variants 
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(Metcalf et al., 2000b; Young et al., 2006). Since the purpose of immunoassays developed for 
microcystins usually is to detect all the microcystins present cross-reactivity is a useful property. 
However, in some assays developed, some variants, e.g. [ADMAdda5]-microcystins, show low 
cross-reactivity (Laub et al., 2002). When the purpose is to determine the presence of specific 
microcystin variants, the demands on the antibody specificity are increased and monoclonal 
antibodies with extraordinary sensitivity and selectivity for e.g. [4-arginine]microcystins have been 
developed (Zeck et al., 2001a). Cross-reacting substances not related to the studied analyte affect 
the immunoassay, depending on their concentration compared to the analyte, their affinity against 
the antibody and the setup of the analysis (Price and Newman, 1997). Antibodies developed for 
microcystins usually also bind to microcystin conjugates of glutathione, cysteine-glycine and 
cysteine produced in detoxification processes of microcystin (Metcalf et al., 2000a; Metcalf and 
Codd, 2003). 
The quantitative determination by immunoassays requires the results to be compared to a 
standard curve based on known concentrations. If MC-LR or an appropriate surrogate is used as a 
calibrating agent for determining the microcystin concentration, the amount of toxin can be 
reported as microcystin-LR equivalents (Harada et al., 1999). The result from the immunoassay can 
thus not directly be correlated to the toxicity of the sample when other variants than MC-LR are 
present.  
Although immunoassays can be classified according to many different criteria, a common way is to 
divide them according to the construction of the method. In a direct competitive immunoassay, 
the antibodies are immobilized on the microtiter plate wells. The sample is added to the well 
together with the labelled antigen. If there are antigens in the sample they compete with the 
added labelled antigens for the binding to the antibodies. Antigens not bound to antibodies are 
washed away, reagents that react with the label are added and the product is detectable as a 
result. The amount of labelled antigen that is bound to the antibody can be measured and the 
result is inversely proportional to the concentration of the antigen in the sample. A high 
concentration of antigen in the sample gives a low signal. Many immunoassays developed for 
microcystins are based on this method (Chu et al., 1989; Chu et al., 1990; An and Carmichael, 
1994; Liu et al., 1996; Carmichael and An, 1999; Mikhailov et al., 2001; Zeck et al., 2001a; Zeck et 
al., 2001b).  
A secondary antibody is quantitatively determined in an indirect competitive immunoanalysis. A 
sample with a primary antibody is added together with the sample to the microtiter well 
immobilized with antigen and is allowed to react. Unbound analytes are washed away and a 
labelled secondary antibody that binds to the primary antibody is added. Free secondary 
antibodies are washed away and a compound that reacts with the label gives a product that can be 
detected. The indirect competitive immunoanalysis is the most commonly used immunoassay that 
have been developed for microcystins (Chu et al., 1989; Saito et al., 1994; Nagata et al., 1995; 
Ueno et al., 1996b; Nagata et al., 1997; Tsutsumi et al., 1998; Metcalf et al., 2000b; Mikhailov et 
al., 2001; Lindner et al., 2004). It is important both in the direct and indirect competitive 
immunoassays that the relative amount of the labelled antigen and the antibody are kept constant 
because the amount of free antigen is compared to a series of standards for a quantitative result. 
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Nagata and co-workers developed a sensitive sandwich ELISA with a detection limit of 2 ng 
microcystin per liter water (Nagata et al., 1999). Sandwich assays are non-competitive two-site 
immunoassays in which antibodies are immobilized in the microtiter well, the sample is added and 
the antibodies bind an epitope on the sample antigen. The well is washed, whereafter a labelled 
secondary antibody is allowed to react with another epitope on the antigen. Small molecules like 
microcystins might not bind two or more antibodies at the same time due to steric hindrance. 
However, anti-idiotype antibodies have been developed that recognize the antibody-microcystin 
complex (Tsutsumi et al., 1998). The free antibodies are washed away, the developing solution is 
added and the product can be measured. The result is directly proportional to the concentration of 
the antigen because the labelled antibody does not bind if the antigen is not present.  
1.4.3.1 Microcystin as antigen 
Antigens with low molecular weights (~300-2000 Da) such as microcystins are called haptens and 
show antigenicity, as they can be recognized by antibodies, but have to be conjugated to a carrier 
to be immunogenic and give rise to a proper immune response (Baier et al., 2000). Many different 
proteins, such as bovine serum albumin (Chu et al., 1989), keyhole limpet hemocyanin (Zeck et al., 
2001a), ovalbumin (Nagata et al., 1995; Zeck et al., 2001b) and soybean trypsin inhibitor 
(Mikhailov et al., 2001), have been used as carriers. However, some proteins, such as BSA, require 
modification for more efficient binding to microcystin (Chu et al., 1982). In many publications the 
carboxy group in glutamate, at position 6 in microcystins, are used for the conjugation to the 
carrier protein (Chu et al., 1989; Nagata et al., 1995; Ueno et al., 1996a). The spacer arm between 
the microcystin and the carrier has usually been carbodiimide (Chu et al., 1982; Chu et al., 1989). 
By varying the spacer arm and the linking location, e.g. aminoethylation of the N-
methyldehydroalanine in microcystins (Moorhead et al., 1994; Mikhailov et al., 2001), antibodies 
with specificity for different epitopes are obtained (Luo et al., 2011). MC-LA conjugated to a 
carrier, polylysine, was an effective immunogen in mice when used in combination with an 
adjuvant, muramyl dipeptide (Botes et al., 1982; Kfir et al., 1986). Microcystin conjugated to 
bovine serum albumin (BSA) through ethylendiamine (EDA) was shown to be an even better 
immunogen in mice (Chu et al., 1989). For antibody generation, immunization with protein 
conjugated microcystin has to be combined with adjuvants like lipopeptides (Baier et al., 2000).  
1.4.3.2 Monoclonal and polyclonal antibodies against microcystins 
The production of monoclonal antibodies demands a considerably heavier work load than the 
production of polyclonal antibodies. When an animal is immunized with an antigen the immune 
response gives rise to polyclonal antibodies, which are heterogenic mixtures of different 
antibodies that each and everyone are specific for an epitope. It is not possible to directly purify 
monoclonal antibodies from a mixture of polyclonal antibodies. Therefore the normal active 
antibody producing B cell and a myeloma cell (a cancer cell) are fused to a hybrid cell, a hybridoma 
(Kohler and Milstein, 1975). Hybridomas divide unrestrictedly as myeloma cells do and possess the 
antibody producing properties of the B cells, and high amounts of monoclonal antibodies can be 
produced. Monoclonal antibodies that originate from a separate hybridoma clone are often 
preferred in both research and diagnostics and in therapeutic purposes. 
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In the production of antibodies against microcystins mice have often been used (Kfir et al., 1986; 
Saito et al., 1994; Nagata et al., 1995; Liu et al., 1996; Baier et al., 2000; Zeck et al., 2001a; Zeck et 
al., 2001b), sometimes also rabbits (Chu et al., 1989; Baier et al., 2000; Metcalf et al., 2000b; 
Mikhailov et al., 2001), and occasionally even sheep (Fischer et al., 2001) and chicken (McDermott 
et al., 1995).  
The first antibodies against microcystins were monoclonal and developed by Kfir et al. (1986). They 
were not developed to an immunoassay but the affinity was determined and it was shown that 
they bound to six different microcystin variants with equal affinity (Kfir et al., 1986). 
The first polyclonal antibodies reported against microcystins were produced by Brooks and Codd 
(Brooks and Codd, 1988). Chu et al. (1989) developed the first enzyme-linked immunoassay that 
was based on polyclonal antibodies by which many natural algal blooms were analyzed. The lowest 
detection limit for microcystins was 0.2 µg/l. The affinity for MC-RR, -LR and -YR was shown to be 
good, but the antibodies cross-reacted poorly with -LY and -LA (Chu et al., 1989). The cross-
reactivity of the antibodies was later tested for 18 different microcystins and nodularins. The 
stereochemistry of the double bond system in Adda was shown to be important for the specificity 
(An and Carmichael, 1994) as well as the arginine in position 4 (Chu et al., 1989). Other polyclonal 
antibodies that cross-reacted with many of the microcystin variants and nodularins were produced 
and developed to an ELISA with a detection sensitivity of 1 µg/l (Metcalf et al., 2000b). The cross-
reactivity showed that MC-LA had the highest affinity, followed by -LR, -LF, -LW, -D-Asp3-RR, -LY 
and nodularin. A good correlation (r2=0.96)  was found between results from HPLC-UV (DAD) and 
ELISA (Metcalf et al., 2000b). An even more sensitive ELISA with polyclonal antibodies was 
developed with a detection limit of 0.12 µg microcystin-LR per litre (Sheng et al., 2006). Broad 
cross-reactivity between several microcystins was reported (Sheng et al. 2006).  
To increase specificity monoclonal antibodies that specifically recognize a region on the 
microcystin molecule have been developed. Nagata et al. (1995) produced 6 different monoclonal 
antibodies against MC-LR, with epitopes recognising arginine in position 4 and Adda in position 5. 
The best antibody was chosen for developing an ELISA with a detection limit of 25 ng/l and more 
than 1 100 samples collected from Japan, Thailand, Germany and Portugal were analysed (Ueno et 
al., 1996b). The sensitivity of an ELISA developed by Fischer et al. (2001) was 20 ng/l and the cross-
reactivity of the antibodies against 7 other microcystins was very good. A sensitivity of 70 ng/l was 
obtained by antibodies from Zeck et al. (2001b) and the cross-reactivity was tested for 12 
microcystin variants and 3 Adda-derivatives and nodularin. Monoclonal antibodies especially for 
microcystins with arginine at position 4 (4-R-microcystins) were produced and developed to a 
sensitive ELISA with a detection limit of 6 ng/l (Zeck et al. 2001a). The cross-reactivity between 4-R-
microcystins was good, whereas the antibodies did not recognize -LY, -LW, -LF and Adda 
derivatives. In another ELISA based on the same commercially available antibodies the detection 
limit was 4 ng MC-LR per liter (Lindner et al. 2004). Khreich et al. recently developed an 
immunoassay able to detect microcystins at 10 ng MC-LR per liter water (Khreich et al., 2009).  
Parts of antibodies can be used as such in immunoassays. Genetically modified antibody fragments 
consisting of one single chain was developed by McElhiney et al. (2000) against microcystins. The 
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antibody fragments were isolated from an assembly of bacteriophages that express different 
antibody fragments on their surfaces (McCafferty et al., 1990). The fragments that were chosen 
were expressed in considerable quantities in bacteria. By choosing an appropriate antibody library, 
sensitive antibodies were found (Strachan et al., 2002). Production of antibody fragments in 
bacteria is fast and cheap and the ethical questions of using animals are avoided (McElhiney et al., 
2000).  
1.4.3.3 Enzyme-linked immunosorbent assay (ELISA) 
The detection of the antibody or the antigen can be made by many different methods. Among 
non-isotopic labels, enzymes compose a versatile group with possibilities of measuring low 
concentrations. Several conjugation possibilities, sensitivity and size have made the horseradish 
peroxidase, HRP, to a popular labelling enzyme (Azevedo et al., 2003). HRP is a commonly used 
enzyme in ELISA and has almost exclusively been used in microcystin labelling, although in one 
publication alkaline phosphatase was used (McDermott et al. 1995). A spectrophotometer is used 
for detection of the signal from HRP. HRP is considered to be a small enzyme though its molecular 
weight is 44000 Da. The high molecular weight of most enzymes is a clear disadvantage. Labelling 
of small molecules with large enzymes causes a large structural change in the antigen, even though 
they still bind to the antibody (Selby, 1999). Labelling of antibodies with enzymes is usually less 
problematic since antibodies themselves are large molecules (Selby, 1999) 
1.4.3.4 Time-resolved fluoroimmunoassay 
Time-Resolved FluoroImmunoAssay (TR-FIA) is an immunoassay where the antibodies or the 
antigen has been labelled with a fluorescent lanthanide, e.g. europium (Soini and Hemmilä, 1979; 
Soini, 1990). Time resolved fluorescence in immunoassays has been used since the 1980s, mostly 
in human diagnostics, but also many other applications have been reported (Hemmilä and Laitila, 
2005). In this thesis, a TR-FIA for the analysis and detection of microcystins was developed.  
Many compounds are in practice weakly fluorescent and some molecules have more intense 
fluorescent properties, like aromatic compounds. Atoms on the other hand are usually non-
fluorescent, with lanthanides being an important exception. Lanthanide ions themselves have 
weak fluorescence due to their poor molar absorptivities and low quantum yields (Bunzli and 
Eliseeva, 2011). The fluorescence of lanthanides can be sensitized and enhanced by forming a 
complex between the lanthanide and a suitable ligand (Soini and Hemmilä, 1979; Bunzli and 
Eliseeva, 2011).  
Fluorescence requires that light has been absorbed, or that energy from outside the system has 
been provided so that an electronic excited state can be accomplished. A molecule that has 
reached the excited state rapidly returns to the ground state. At the same time a photon is 
emitted. The process between absorption and emission of light can be illustrated with a Jabłoński 
diagram (Fig. 4). 
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Figure 4. A Jabłoński diagram, modified from Lacowicz, 1999. S0, S1 and S2 are singlet ground, first 
and second electronic states, respectively. Transition to S0 is called fluorescence. Some fluorophores 
can undergo a spin conversion (intersystem crossing) to a triplet state, denoted T. Transition from 
T1 to S0 is called phosphorescence. 
The lifetime of a fluorescent compound is the time from the excitation to the return to the ground 
state. The chelating ligand absorbs excitation energy and transfers it to the central atom which is 
excited from the ground state (S0) to a higher state (usually S1 or S2). Energy is then transferred 
through intersystem crossing to the triplet (T) state (Fig. 4) and thereafter, for e.g. europium, to 
the central atom (Soini and Hemmilä, 1979). When the metal returns to the ground state from the 
excited state, a photon is emitted.   
Due to the short lifetime of conventional fluorophores the excitation is usually done with a 
continuous light source and the emission is observed continuously. When using time resolved 
fluorescence the sample is exposed to a pulsed source with a very short light flash of 1 µs from a 
xenon light source (Soini and Hemmilä, 1979). Fluorescence is usually a short-lived phenomenon 
with most of the fluorophores having a lifetime around 10 ns. Lanthanide ions have several ground 
states and the f-f transition is forbidden. Lanthanides show long-lived fluorescence since the 
higher orbitals are protected, with lifetimes up to a few milliseconds for chelates of europium and 
terbium (Hemmilä and Mikola, 1990; Hemmilä and Mukkala, 2001). The emission continues long 
after the instant background fluorescence has disappeared. For example, the fluorescence of 
europium is measured in 400 µs after a delay time of 400 µs (Fig. 5). After 1 ms the excitation is 
repeated and the whole measurement cycle is repeated 1000 times per second. All the photons 
that are emitted during the measurement cycle are expressed as cps (counts per second).  Hereby 
the intensity is integrated for a specific time period.  
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Figure 5. Time-resolved fluorescence measurements of europium chelates. Excitation occurs at 340 
nm. Fluorescence is measured in 400 µs after a delay time of 400 µs, at 613 nm. Picture drawn by 
the author according to Soini and Hemmilä, 1979. 
The different lanthanides are distinguished according to their quenching time, which is 
nanoseconds for the chelates of ytterbium, neodymium and erbium, and milliseconds for 
dysprosium chelate (Hemmilä and Mikola, 1990; Hemmilä and Mukkala, 2001). This property of 
the lanthanides results in a simple and efficient way to eliminate interference from the 
background (Soini and Lövgren, 1987). When using time-resolved fluorometry the emission is 
measured after a delay time (10-400 µs) has elapsed from the excitation. This makes it possible to 
avoid the short lived fluorescence of 10 ns that the non-specific background gives rise to. Usually 
TR-FIA has better sensitivity than ELISA because the sensitivity in other immunoassays is restricted 
by non-specific background noise (Hemmilä and Mikola, 1990). Interfering noise can be avoided by 
measuring the specific signal after a time delay, which is possible with time-resolved fluorescence 
(Soini and Lövgren, 1987). 
Energy of the emission is usually less than that of the absorption, and fluorescence usually occurs 
at a lower energy and at a longer wavelength. This phenomenon is called Stokes shift and was 
named after Sir G.G. Stokes who made the observation for the first time in 1852 (Stokes, 1852). 
Energy is lost for instance at the rapid decay to the lowest vibrational levels. The europium chelate 
has a Stokes shift of 270 nm, which means that the distance between the wavelength of the 
excitation and the emission is very wide (Hemmilä, 1988). Moreover, with narrow emission 
profiles (10 nm) the specific signal can easily be separated from the non-specific light scattering 
and the background (Soini and Hemmilä, 1979). 
A stable europium carrier allowing simple and reliable labelling of antibodies or analytes is e.g. 
EDTA derivatives (Soini and Hemmilä, 1979). At excitation, energy is transferred from the chelate 
to the metal ion. Due to weak fluorescent properties of the conjugate, a new complex needs to be 
formed. By adding an enhancer solution containing e.g. a β-diketone like 2-naphtoyl 
trifluoroacetate a new highly fluorescent chelate is produced at low pH conditions (Hemmilä et al., 
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1984). The chelate that is formed has the chromophore needed for the light absorption that can 
be transferred to the lanthanide through resonance energy transfer. To keep the fluorescence 
efficient, water needs to be expelled since it acts as an efficient quencher (Hemmilä et al., 1984). 
This can be accomplished by adding a fatty acid derivative, e.g. trioctylphosphine, dissolved in a 
detergent, e.g. Triton X-100, since they form an insulating sheath around the lanthanide complex 
by formation of a micelle (Hemmilä et al., 1984). 
1.5 RISK ASSESSMENT FOR HUMAN HEALTH 
Risk assessment is the scientific discipline of the risk management process and includes the 
process of evaluating the impact of contaminants on the well-being of individuals and populations.  
Cyanobacteria produce a variety of bioactive compounds, some of which cause adverse health 
effects in mammals and/or aquatic organisms due to toxic properties (Codd et al., 2005). Health 
effects related to cyanobacteria are derived from consumption of or contact with contaminated 
water (Falconer and Humpage, 2005). For the estimation of hazard to human health, the total risk 
of a specific toxin should take into consideration the toxic potential of the substance, dose 
response relationship, possible routes for human exposure and, prevalence and concentration of 
the toxin. 
The relationship between water and health is complex. Several diseases, e.g. cholera, have a direct 
connection to water supplies and spread easily with water (Reidl and Klose, 2002). Cyanobacteria 
however are unable to colonize, invade and grow in human and animal hosts and are therefore not 
regarded as waterborne pathogens in the safety assessment of drinking water (Codd et al., 2005).  
1.5.1 Hazard identification  
Human and animal poisoning episodes as well as toxicological studies show that cyanobacterial 
toxins can cause adverse human health effects (Codd et al., 2005; Wiegand and Pflugmacher, 
2005; Golubic et al., 2010). Toxicosis in humans is diverse, ranging from mild to fatal, and includes 
symptoms of gastroenteritis, abdominal pain, kidney and liver damage, nausea, vomiting, sore 
throat, blistered mouth, flu-like symptoms, ear and eye irritation, rashes etc (Codd, 2000; Codd et 
al., 2005).  
Epidemiological evidence from the Caruaru dialysis center in Brazil 1996 shows that 76 people died 
following intoxication by microcystin (Jochimsen et al., 1998; Carmichael et al., 2001; Azevedo et 
al., 2002). In Armidale, Australia 1981, human liver damage was observed due to microcystins in 
the water released from cells after an algicide treatment of a heavy cyanobacterial bloom 
(Falconer et al., 1983). Complete epidemiological data are lacking in several cases but 
cyanobacterial toxins were involved in human injuries for example in Ohio (Tisdale, 1931), Harare, 
Zimbabwe (Zilberg, 1966) and Palm Island, Australia (Byth, 1980). Several cases of microcystin 
causing adverse effect in wildlife population have been reported (Stewart et al., 2008). Linking the 
observed adverse effect with exposure to microcystins can however be difficult, since the 
exposure has often been to a mixture of substances.   
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Toxicological experiments, conducted under controlled laboratory conditions, provide important 
information on the toxic potential of microcystins. Direct conclusions from animal or cell 
experiments can seldom be directly extrapolated to human health effects due to e.g. physiological 
differences between species (Dybing et al., 2002). Moreover, results from extrapolations are 
subject to great uncertainty and translations cause problems due to multifactorial etiology, e.g. in 
cancer (Dybing et al., 2002). The way microcystins enter the organism, organs and cells has a 
crucial effect on the distribution of microcystins and their toxicity in vivo (Gaudin et al., 2008). 
Especially data regarding other variants than MC-LR is limited.   
Microcystins exhibit their toxic action by inhibiting protein phosphatases 1 and 2A (Eriksson et al., 
1990; MacKintosh et al., 1990; Runnegar et al., 1995a; Craig et al., 1996). Also other members of 
serine/threonine phosphatases (PP3, PP4, PP5) have been suggested to be inhibited (Prinsep et al., 
1992; Hastie et al., 2005). The conformation of MC-LR allows the molecule to bind with high 
affinity to PP1 (Goldberg et al., 1995). The long hydrophobic Adda side chain fits smoothly into a 
hydrophobic groove in PP1, and the leucine side chain packs closely to Tyr272 near the active site 
(Goldberg et al., 1995). Structural and conformational changes in the molecule have been shown 
to affect the protein phosphatase inhibition capacity (Mountfort et al., 2005). However, structure-
activity relationships are scarcely available for microcystins, especially for other microcystin 
variants than MC-LR. After an initial, rapid, non-covalent binding, mediated principally by the Adda 
moiety (Goldberg et al., 1995), N-methyldehydroalanine undergoes a covalent linkage to Cys 273 
in PP1 or Cys266 in PP2A (MacKintosh et al., 1995; Runnegar et al., 1995a). This makes the 
inhibition irreversible. Hyperphosphorylation of many cellular proteins is the primary acute effect 
of microcystins. Especially hepatocytes are susceptible as they have several types of organic anion 
transport proteins, also responsible for e.g. bile acid uptake. Some of these proteins actively take 
up microcystins with different selectivity (Fischer et al., 2005; Monks et al., 2007; Fischer et al., 
2010). Other transporters might also be involved, for example ABC transporters have been 
suggested as a route of entry for microcystins (Pearson et al., 2004; Fischer et al., 2010). Due to 
the active uptake the main target of microcystins is the liver. The cytoskeleton of cells is disrupted 
which causes loss of cell-cell contacts and intra-hepatic haemorrhage and death occurs due to 
hypovolemic shock (Runnegar and Falconer, 1986; Falconer and Yeung, 1992; Runnegar et al., 
1993). Microcystins also affect liver aldehyde dehydrogenase 2 and inhibits ATP synthase and 
these changes have been associated with apoptosis (Mikhailov et al., 2003; Chen et al., 2006). 
Uptake of microcystins occur through specific organic anion transporters, and as mentioned 
earlier, different microcystins variants have different affinities for the OATP:s (Runnegar et al., 
1991; Runnegar et al., 1995a; Fischer et al., 2005). Microcystins exhibit a predominantly hepatic 
organotropism, although several other cell types and organs are affected as well (Falconer, 2008). 
In addition to whole-animal experiments cell experiments with cells derived from humans, mice, 
monkeys, fish etc have been done. The kidneys show in vitro and in vivo toxic effects of 
microcystins (Nobre et al., 1999; Milutinovic et al., 2002; Milutinovic et al., 2003; Gaudin et al., 
2008; Alverca et al., 2009). The intestine as well as the heart, brain, lungs, immune system and the 
reproductive system have been shown to be affected by microcystins (Humpage et al., 2000; 
Lankoff et al., 2004; Picanco et al., 2004; Dietrich and Hoeger, 2005; Fischer et al., 2005; Ding et al., 
2006; Zegura et al., 2008; Herfindal et al., 2009; Qiu et al., 2009).  
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Microcystins cause an excessive formation of reactive oxygen compounds and consequently to 
oxidative damage in cells (Ding et al., 1998; Ding and Nam Ong, 2003; Amado and Monserrat, 
2010). The increased levels of reactive oxygen species have been shown to be associated with 
genotoxic and carcinogenic effects (Zegura et al., 2003; Zegura et al., 2004; Dittmann and 
Wiegand, 2006). Repeated consumption of low levels of microcystin have been shown to cause 
increased liver weight, hepato-histological damage (Heinze et al., 1999), liver tumours (Nishiwaki-
Matsushima et al., 1992; Bouaicha et al., 2005; Herfindal and Selheim, 2006; Li et al., 2009; 
Martinez Hernandez et al., 2009) and kidney damage (Milutinovic et al., 2003). Epidemiological 
studies have shown that microcystins are linked to the high prevalence of primary liver cancer in 
risk areas, and to cancer in the large intestine and the rectum (Yu, 1995; Ueno et al., 1996a; Zhou 
et al., 2002; Herfindal and Selheim, 2006). 
1.5.2 Dose-Response Assessment 
Comprehensive dose-response studies in pigs, mice and rats have resulted in LOAEL (lowest 
observed adverse effect level) and NOAEL (no observed adverse effect level) values (Falconer et 
al., 1994; Fawell et al., 1994; Heinze, 1999). The Tolerable Daily Intake (TDI) for microcystin-LR, 
established by WHO, is 0.04 µg/kg body weight per day (WHO, 2011). This dose level is considered 
not to cause any kind of adverse effect over a life time. The value is based on the NOAEL value that 
is 40 µg/kg/day in mice (Fawell et al., 1994) and a security factor of 1000. The security factor takes 
into account inter-species extrapolation, intra-species variation and less-than-lifetime-exposure. 
The assumptions were: adult body weight of 60 kg, drinking water consumption of 2 l daily, and an 
allocation factor for the exposure from drinking water 0.8 (WHO, 2011). The provisional guideline 
value adopted by WHO for MC-LR have been criticized because new toxicity data are available for 
many of the variants and a tightened guideline value has been discussed (Dietrich and Hoeger, 
2005). The effect of long-term exposure is also quite unclear since the study on pigs lasted for only 
44 days. Experience from China where the increased rate of primary liver cancer, and other related 
diseases, have been linked to exposure of microcystins, implies a stricter guideline value (Ueno et 
al., 1996a). Toxin exposure resulting from contaminated food (e.g. seafood) has not been 
considered in the NOAEL studies (Ibelings and Chorus, 2007).  
The potency of a toxin is expressed as the amount required to produce an effect of given intensity. 
Most microcystins showed an acute LD50 value of 50-600 µg/kg (mouse, i.p.). Pure MC-LR, injected 
intraperitoneally, has an LD50 value (mouse) of 50 µg/kg, whereas orally administrated MC-LR had 
an LD50 value of 10.9 mg/kg (Yoshida et al., 1997). Another study showed that the LD50 value in 
mouse varies from 250 µg/kg, i.p. or intranasal administration, to 3000 µg/kg, gastric intubation 
(Fitzgeorge et al., 1994). Microcystins that have hydrophobic amino acids such as, tyrosine (MC-
LY), tryptophan (MC-LW) and phenylalanine (MC-LF) may be more toxic than MC-LR in some 
organisms (Ward & Codd 1999). For example the cells of Tetrahymena pyriformis (a freshwater 
protozoa commonly used in bioassays) were more sensitive to the tyrosine-containing MC-YR 
compared to the hydrophilic MC-LR but most sensitive to MC-LW and MC-LF (Ward and Codd, 
1999). However, no LD50 value has been determined for MC-LW and MC-LF. 
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Detoxification of microcystin-LR in the liver occurs at least in part by conjugation to glutathione 
(GSH) catalysed by glutathione S-transferase (GST) (Kondo et al., 1996; Pflugmacher et al., 1998; 
Takenaka, 2001). GSH is thought to be one of the most important non-enzymatic antioxidants and 
is the first protection against reactive oxygen compounds. Hepatocytes exposed to MC-LR show an 
initial increase, followed by a decrease of cellular glutathione (Ding et al., 2000). Microcystins 
induce the glutathione synthesis, and the increase of the GST activity is regulated at the 
transcription level (Wiegand et al., 1999; Gehringer et al., 2004). Also conjugation of microcystins 
with cysteine is possible (Kondo et al. 1996). The complex formed after the conjugation is 
transported to the kidneys and the intestine for secretion (Ito et al., 2002).  
1.5.3 Exposure assessment 
In exposure assessment there is a need to estimate the extent, frequency and duration of contact 
between cyanobacterial toxins and an individual or a population. The dose that is received by the 
individual or the population varies for example with location (distance to source), lifestyle and 
physiology. Particular care needs to be taken to determine the exposure of susceptible 
populations. Contact with microcystins occurs via the environment as well as through consumer 
products, like consumption of contaminated drinking water, food and dietary supplements. Oral, 
inhalation and cutaneous exposures to microcystins are the most likely routes of contact. Two 
episodes of human microcystin exposure by the intravenous route have been documented 
(Jochimsen et al., 1998; Soares et al., 2006).  
A cyanobacterial bloom is a mass occurrence of cyanobacteria at the water surface. The blooms 
are dynamic and vary both with weather and time. The increased prevalence of the cyanobacterial 
blooms can often be associated with eutrophication, often caused by humans (Anderson et al., 
2002). Usually cyanobacterial blooms occur in summertime (in the northern latitudes) because 
most cyanobacteria have their maximal growth at temperatures over 25°C (Sivonen and Jones, 
1999). Global warming might promote the growth of cyanobacteria (Hallock, 2005). The intensity 
and the extent of cyanobacterial blooms are difficult to predict. Calm weather promotes 
cyanobacterial growth, whereas wind and currents can transport the cyanobacterial masses long 
distances, disperse them or flush them on shore (Dziallas and Grossart, 2011). Microcystin 
concentrations detected in natural waters are usually between 0.1 – 10 µg/l, but higher 
concentrations have been reported, with an extreme case of 36000 µg/l (Ueno et al., 1996b; 
Sivonen and Jones, 1999). Sometimes a bloom can occur temporarily, other times for a longer 
period of time. Some cyanobacteria problems can be connected to the increased ship traffic 
(Lindholm et al., 2001; Doblin et al., 2007). Cyanobacteria are transported in ballast water and 
contribute to spreading of toxin-producing species around the world (Lindholm et al., 2001; Doblin 
et al., 2007). Nutrients are also available from the bottom sediments, both due to natural 
processes and anthropogenic loadings (Lindholm et al., 2001; Sellner et al., 2003; Doblin et al., 
2007). Increase in temperature and phosphorous concentrations seemed to promote growth of 
toxic Microcystis cells (Davis et al., 2009). On the other hand, different cyanobacterial species 
respond to nutrient concentrations in different ways and there is no simple relationship 
(Kaebernick and Neilan, 2001; Vezie et al., 2002; Vuorio et al., 2005; Håkanson et al., 2007).  
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Microcystins have different bioavailability and toxicity in vivo (Sivonen and Jones, 1999; Gupta et 
al., 2003; Chen et al., 2007). 80 % of the microcystin exposure is estimated to occur through intake 
of drinking water (Kuiper-Goodman et al., 1994). The risk for the exposure through drinking water 
can be estimated to be high in areas where toxic cyanobacteria occur, drinking water resources are 
restricted and the water purification is limited. Especially in these areas monitoring of the drinking 
water is of importance. Use of algicides (e.g. copper sulphate and hydrogen peroxide) in drinking 
water reservoirs can rapidly release large amounts of toxins into the water and some of the short-
term human exposure incidences can directly be linked to bloom clearance actions (Jones et al., 
1994; Kuiper–Goodman et al., 1999; Ross et al., 2006; Qian et al., 2010; Jancula and Marsalek, 
2011). 
Microcystins are able to bioaccumulate in various aquatic species, including fish, bivalves, 
molluscs, zooplankton, crabs and crayfish (Eriksson et al., 1989; Vasconcelos, 1995; Carbis et al., 
1997; Wiegand and Pflugmacher, 2005; Malbrouck and Kestemont, 2006). The main accumulation 
site is the digestive tract in bivalves, the hepatopancreas in crayfish, and the liver in fish 
(Vasconcelos, 1995; Carbis et al., 1997; Vasconcelos et al., 2001). The accumulation in e.g. fresh 
water molluscs is most pronounced in highly contaminated waters and in adult animal species 
(Gérard et al., 2009). Differences in the uptake and detoxification mechanisms affect microcystin 
bioaccumulation (Zurawell et al., 2005). Microcystins can also be present in plants, e.g. lettuce and 
mustard (Kurki-Helasmo and Meriluoto, 1998; Codd et al., 1999; McElhiney et al., 2001; Wang et 
al., 2011). Microcystins have been shown to covalently bind to target proteins (Craig et al., 1996). 
The bioavailability of the covalently bound toxins for the next trophic level is not known (Dietrich 
and Hoeger, 2005). The proportion of the covalently bound toxins from the total contamination 
has been reported to vary in different organisms and exposure conditions. 
Chronic exposure to microcystins have revealed an average value of 0.39 ng/ml in human serum 
samples taken from people exposed to microcystins below the range of WHO guidelines (Chen et 
al., 2009). A positive correlation was found between microcystin concentrations and the 
concentration of the enzymes alanine and aspartate aminotransferase, alkaline phosphatase, and 
lactate dehydrogenase (Chen et al., 2009). The WHO guideline value of microcystin-LR has been 
suggested to be reassessed since liver damage might occur at low exposure levels (Chen et al., 
2009).  
Cyanobacterial blooms are seldom monotypic, rather they contain different species of 
cyanobacteria (Fewer et al., 2009). Blooms that produce microcystins have been reported from all 
over the world (Wood et al., 2008). The probability that a bloom produce toxins was shown to be 
between 25 and 95% (Sivonen and Jones, 1999). The cyanobacterial blooms in Finland had toxins 
in 45% of the cases (Sivonen et al., 1995). The presence of toxins cannot be predicted by 
determining the dominating species, since only half of the blooms by Microcystis are hepatotoxic 
(Namikoshi and Rinehart, 1996). There are morphologically identical strains that can be either toxic 
or non-toxic (Ohtake et al., 1989). Studies made in Denmark, Germany, Czech Republic and South 
Korea showed that 80-90% of the blooms dominated by Microcystis spp. were hepatotoxic 
(Chorus, 2001). If the bloom is dominated by Planktothrix the risk for hepatotoxins seemed to be 
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even greater (Chorus, 2001). At growth-limited conditions microcystin producing Planktothrix 
strains seemed to outcompete non-microcystin producing Planktothrix strains (Briand et al., 2008). 
Cyanobacteria are able to produce several microcystins simultaneously although only a few usually 
dominate in any single strain (Mikalsen et al., 2003; Fewer et al., 2009; Kurmayer and Christiansen, 
2009). Variations in the production and the composition of microcystins are determined by genetic 
factors as well as environmental factors (Sivonen and Jones, 1999; Tooming-Klunderud et al., 2008; 
Kurmayer and Christiansen, 2009). In Australia, 23 different microcystins were characterized in a 
bloom of Microcystis aeruginosa, none of which was MC-LR (Jones et al., 1995). Microcystis spp. 
often produce the microcystin variants -LR, -YR and -RR (Watanabe et al., 1988). In Finland the 
variants MC-LR and MC-RR, and especially their demethylated variants (amino acid 3 and/or 7) are 
most common (Sivonen et al., 1995). Anabaena species produce mainly 2-4 of these microcystins 
whereas Planktothrix species often produce only one microcystin, which usually is a demethylated 
variant of MC-LR or MC-RR (Sivonen et al., 1995). Exposure to different microcystins raises needs 
to evaluate also other variants than MC-LR for their chemical, physical and biological properties. 
Especially those variants that have amino acids of more hydrophobic character as they have been 
implied to be more toxic (Ward and Codd, 1999; Fischer et al., 2010).  
1.5.4 Risk characterization 
Risk characterization is the final phase in the health risk assessment process and sums up the three 
former phases: hazard identification, dose-response assessment and exposure assessment. The 
quantity and quality of the data, the biological relevance and the consistency of the study results 
are considered carefully and conclusions are drawn regarding the health risk implicated in 
exposure to microcystins. The more comprehensive data that is available, the lower uncertainty in 
risk assessment and the more precise guideline values can be estimated. There are insufficient 
data to determine a health-based guideline value for most cyanobacterial toxins (Donohue and 
Orme-Zavaleta, 2008). Several countries have regulations or guidelines for microcystins in drinking 
water, and in some cases also in water used for recreation and agriculture (Chorus, 2005; Burch, 
2008). Regarding microcystins there is a wide variation in the toxicity due to the several variants 
(Feurstein et al., 2010). There is a need to increase the toxicology database for microcystin variants 
other than MC-LR. Also the congener specific uptake of different microcystins needs to be 
elucidated (Feurstein et al., 2010). Risk characterization should be performed for a variety of 
microcystin analogues.  
Additive, synergistic, potentiating or antagonistic effects caused by other compounds in a 
cyanobacterial extract complicate further the estimation of toxicity (Donohue and Orme-Zavaleta, 
2008; Jokela et al., 2010). Cyanobacteria produce a whole variety of bioactive compounds and 
several studies indicate that there are many non-identified components along with chemically 
characterized cyanotoxins. These new components can evoke toxic effects that can be even more 
pronounced (Pietsch et al., 2001; Šuput et al., 2002; Buryskova et al., 2006). Some components 
seem to mediate the release of other compounds which can amplify the toxic effect of known 
cyanotoxins (Sedmak and Suput, 2002), and may induce systemic genotoxicity in mammals 
(Sedmak et al., 2008).  
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Identification and classification of different microcystin variants has proven challenging. When 
analysing microcystins in water the method chosen should be 1) sensitive enough to meet the 
health risk assessment requirements and 2) able to characterise the concentration of specific 
microcystin variants. Moreover, a rapid speed of response is desirable. Efforts should be put on 
developing detection methods for analysing microcystin variants other than MC-LR.  
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2 AIMS 
The overall aim of this PhD thesis was to provide tools and insight for risk assessment. The work 
consisted of the following steps: 
I. Development of a sensitive time-resolved immunoassay TR-FIA for microcystins. 
II. Screening of waterbodies on Åland Islands, SW Finland, for microcystins, with special 
interest to compare TR-FIA and ELISA to other detection methods.  
III. Elucidation of interactions of different microcystin variants with artificial lipid membranes 
in order to study membrane effects of more hydrophobic microcystins. 
IV. Comparison of the Caco-2 cellular toxicity of MC-LR, MC-LW and MC-LF. 
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3 MATERIALS AND METHODS 
3.1 REAGENTS AND EQUIPMENT 
L-α-phosphatidylcholine (egg) was purchased from Avanti Polar-Lipids, Inc (Alabaster, AL), 
cholesterol from Sigma Chemicals (St Louis, MO), and TMA-DPH from Molecular Probes (Eugene, 
OR). 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) and 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine (POPC) was purchased from Avanti Polar Lipids, Inc. 6-dodecanoyl-2-
dimethylaminonaphtalene (Laurdan) was obtained from Molecular Probes (Leiden, The 
Netherlands). Cholesta-5,7,9(11)-trien-3-beta-ol (CTL) was synthesized according to the method 
described by Fischer et al. (Fischer et al., 1984) and purified using reversed-phase HPLC (Björkbom 
et al., 2008). Culture media and supplements used for the maintenance of Caco-2 cells were 
purchased from Sigma. The water used was purified on a Milli-Q instrument (Millipore, Molsheim, 
France) to 18.2 MΩcm. All other reagents and buffers were of analytical or chromatographic grade. 
Polystyrene microtiter plates were from FluoroNunc (Nunc, Roskilde, Denmark). The plates were 
washed with a 1296-026 Delfia Platewash (PerkinElmer, Turku, Finland) and a 1296-003 Delfia 
Plateshake (PerkinElmer, Turku, Finland) was used. Excitation at 340 nm and emission at 613 nm 
was measured with a 1232 Delfia Fluorometer (PerkinElmer, Turku, Finland) or a 1420 Victor 
multilabel fluorometer (PerkinElmer, Turku, Finland).  
3.2 PURIFICATION OF MICROCYSTINS 
MC-LR, MC-LW and MC-LF were purified from Microcystis PCC 7820, cultured in the laboratory in 
Z8 medium according to Staub (Staub, 1961) under constant illumination (PowerGlo T8 1800K 15 
W) (R.C. Hagen Inc, West Yorkshire, UK) and aeration (Spoof and Meriluoto, 2005). Briefly, the 
cyanobacteria were grown in room temperature and diluted (1:20) into fresh growth medium 
every 3-4 weeks. For harvesting, the cyanobacteria were filtered on GF/A filters. Purification of 
microcystins started with freeze-thawing of harvested cyanobacteria and extraction with methanol 
in a bath sonicator, dilution with water, filtration, and binding to BondElut C18 columns (Varian, 
Walnut Creek, CA) (Spoof and Meriluoto, 2005). Fractions were collected after preparative C18 
HPLC and concentrated by BondElut columns (Spoof and Meriluoto, 2005). Reversed-phase HPLC 
was used to quantify MC-LR, MC-LF and MC-LW (Meriluoto et al., 2000). Anabaena sp. 90 (culture 
collection of prof. Kaarina Sivonen, Helsinki University, Finland), cultured in Z8 medium without 
nitrogen addition and under constant illumination and aeration, was extracted with methanol and 
microcystins were analysed by HPLC. 
3.3 PRODUCTION OF ANTIBODIES 
Monoclonal antibodies were produced by conventional methods as described in Mikhailov et al., 
2001.  
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3.4 DERIVATISATION OF MICROCYSTIN 
Labelling of MC-LR included preparation of the toxin, the actual labelling and purification of the 
labelled product. Aminoethanethiol-MC-LR was made by adding a 3000-fold molar excess of 2-
aminoethanethiol to MC-LR in 0.1 M sodium bicarbonate buffer, pH 9 (Moorhead et al., 1994). The 
mixture was incubated for 1 h at 50°C, cooled to room temperature and acetic acid was added to 
stop the reaction according to the manufacturer’s description (PerkinElmer, Turku, Finland). The 
product, aminoethanethiol-MC-LR (Fig. 6) was purified on a BondElut column. 
 
 
 
 
 
 
 
 
 
Figure 6. Conjugation of MC-LR with aminoethanethiol. 
 
Aminoethanethiol-MC-LR was dissolved in labelling buffer (50 mM NaHCO3, 0.15 M NaCl, pH 8.5) 
and mixed with the Eu-Labelling reagent, DTTA (europiumchelate of N1-(p-isotiocyanatobenzyl)-
dietylentriamine-N1,N2,N3,N3-tetraacetic acid; Fig. 7; PerkinElmer, Turku, Finland). DTTA forms a 
stable complex with Eu3+ and the aromatic isothiocyanate group reacts with the free amino group 
and a stable, covalent thiourea bond is formed. After incubation overnight at room temperature, 
fractions were collected in semipreparative C18 HPLC and the specific activity of the europium 
chelate was measured. Mass of the final product, MCLR-Eu, was verified by MALDI-TOF MS 
(Matrix-Assisted Laser Desorption Ionization – Time-of-Flight Mass Spectrometry; Finnigan MAT 
Ltd, Thermo BioAnalysis, UK), and performed by the Centre of Biotechnology (Turku, Finland). 
Since europium is released from the chelate at the low pH used in MALDI-TOF MS analysis the final 
product was detected only without europium.  
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Figure 7. Conjugation of aminoethanethiol-MC-LR to the europium chelate. 
 
3.5 EXTRACTION OF FIELD SAMPLES 
In year 1999 field samples were collected from 55 lakes on the Åland Islands and analysed by 
HPLC. The samples, 25 - 200 ml, were filtered through Whatman GF/C filters (diameter 25 mm). 
The filters were air-dried, frozen in glass tubes, thawed and 100 µl of water was added to each 
filter. The filters were freeze-thawed once more and extracted with 2 ml methanol in a bath 
sonicator (Branson B2210, Danbury, CT) for 15 min. The extraction was repeated twice. Argon at 
50°C was used to evaporate the combined extracts, about 6 ml, to dryness. After redissolving in 
200 µl methanol, the residue was centrifuged at 10000 x g in 10 min and the supernatant was 
analysed with HPLC. 
In year 2000 field samples were collected from another 79 lakes on the Åland Islands, making it a 
total of 134 lakes. Pretreatment of the samples were simplified: filters were freeze-thawed twice 
and 1 ml 75% methanol was added for the extraction in the bath sonicator for 15 min. Use of 75% 
methanol improves the extraction of MC-RR in comparison with 100 % methanol (Fastner et al., 
1998). The extracts were centrifuged as described earlier and analysed by HPLC, TR-FIA and PPIA.  
In 2001 field samples were filtered on GF/C filters (diameter 25 mm), air dried and freeze-thawed 
twice and extracted with 1.2 ml 75% methanol in a bath sonicator (Branson 2519E-MT, Danbury, 
CT) for 15 min. GF/C filters with a diameter of 47 mm were extracted with 2 ml 75% methanol. The 
samples were further sonicated with a probe sonicator (Branson Sonifier II W-250, Danbury, CT) 
for 1 min. The extracts were centrifuged at 10000 x g for 10 min and divided into aliquots and 
analysed by HPLC-UV, LC-MS and ELISA. 
3.6 ANALYSIS BY TR-FIA  
The monoclonal antibodies used in paper I were incubated overnight at +4°C in 0.2 M phosphate 
buffer, pH 7.0, in polystyrene microtiter plates. The next day the wells were washed with 5 mM 
Tris–HCl pH 7.8, 0.15 M NaCl, 0.05% Tween 20. Field samples that potentially contained 
microcystins were added to wells in triplicate together with MCLR-Eu dissolved in Assay Buffer 
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(PerkinElmer). Standards of different MC-LR concentrations and negative controls were dissolved 
in 4.5% methanol. After 1 h shaking the washing procedure was repeated and 100 µl Enhancement 
Solution (PerkinElmer) was added. Measurement of time-resolved fluororescence (exc. 340 nm, 
em. 613 nm) was performed after 15 min incubation. 
3.7 HPLC 
Microcystins in Anabaena sp. 90 extract and field samples from 1999, 2000 and 2001 were 
analysed by HPLC. For information on columns, mobile phases, gradient and flow rate used see 
Table 2. Semipreparative HPLC was used to purify MCLR-Eu. The HPLC system used consisted of a 
Shimadzu LC-10AT (Kyoto, Japan) pump coupled to a UV diode array detector Merck–Hitachi L-
7450A (Darmstadt, Germany). The quantitative calculations were made on chromatograms at 238 
nm. Samples were injected with a Shimadzu SIL-9A autoinjector. The column temperature was 
40°C. 
3.7.1 Semipreparative HPLC-UV 
For purification of MCLR-aminoethanethiol a Nucleosil 100 5 C18 column (Macherey-Nagel, Düren, 
Germany), 250 mm×4 mm i.d. was used. Mobile phase consisted of solvent A (27% acetonitrile and 
73% 13.5 mM ammonium acetate) and B (80% acetonitrile and 20% 13.5 mM ammonium acetate). 
A gradient was used and the percentage of solvent B changed in a linear manner according to 
following: at 0 min concentration of B was 0%, at 12 min 0%, at 30 min 25%, at 32 min 25% and at 
34 min 0%. Flow rate 1 ml/min and the total run time was 35 min. 
For purification of MCLR-Eu a Nucleosil 100 7 C18 column (Macherey-Nagel, Düren, Germany), 
250 mm×10 mm i.d. was used. Mobile phase consisted of solvent A (2 volumes of water and 1 
volume of solvent B) and B (27% acetonitrile and 73% 13.5 mM ammonium acetate). A gradient 
was used and concentration of solvent B changed in a linear manner according to following: at 0 
min concentration of B was 0%, at 20 min 100%, at 45 min 100% and at 50 min 0%. Flow rate used 
was 2 ml/min and the total run time was 51 min. 
3.7.2 Analytical HPLC-UV 
To elucidate the microcystin profile in cultured cyanobacteria as well as in environmental samples 
the following columns, mobile phases, gradients and flow rates were used (Table 2). 
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Table 2. Stationary phase and mobile phases used in analytical HPLC-UV work 
 Column Mobile phase Gradient Flow rate 
   Time (min) Solution B (%) ml/min 
Anabaena 
extract 
Nucleosil 100 3 C18, 
150 mm×2 mm i.d. 
(Phenomenex, 
Torrance, CA) 
Solution A: 20% ACN 
+ 80% 13.5 mM 
ammonium acetate. 
Solution B: 100% ACN 
0 
30 
32 
34 
0 
20 
20 
0 
0.2 
Field 
samples 
1999 
Nucleosil 100 3 C18, 
150 mm×2 mm i.d.  
Solution A:  
0.05% TFA 
Solution B:  
100% ACN 
0 
35 
36 
38 
60 
25 
70 
70 
25 
25 
0.25 
Field 
samples 
2000 
Discovery RP-
Amide C16, 150 
mm×2.1 mm i.d. 
(Supelco, 
Bellefonte, PA) 
Solution A:  
0.05% TFA 
Solution B:  
100% ACN 
0 
25 
27 
28 
45 
20 
65 
65 
20 
20 
0.3 
Field 
samples 
2001 
Discovery RP-
Amide C16, 150 
mm×2.1 mm i.d.  
Solution A:  
0.05% TFA 
Solution B:  
100% ACN 
0 
25 
27 
28 
45 
20 
65 
65 
20 
20 
0.3 
 
3.7.3 HPLC-ESI-MS 
The LC-MS instrument consisted of a HPLC Agilent 1100 (Agilent Technologies, Waldbronn, 
Germany) coupled to a Micromass (Manchester, United Kingdom) Quattro Micro triple quadrupole 
mass spectrometer with an electrospray interface. The toxins were separated on Merck Purospher 
STAR RP-18e column, 30 mm×4 mm i.d. Mobile phase consisted of solution A (0.5% formic acid) 
and B (acetonitrile). Concentration of solution B was changed in a linear manner according to 
following: concentration of B at 0 min was 25%, at 10 min 70%, at 11 min 70% and at 11.1 min 
25%. Flow rate was 0.5 ml/min. Capillary voltage was 3.8 kV and the cone voltage 80 V. 
Temperature of the desolvation gas (nitrogen) was 350°C and flow rate 615 l/h. Temperature of 
the ion source was 120°C. 
3.8 IMMUNOASSAY 
For ELISA 50 µl from the field sample extract was evaporated to dryness at 50°C. The samples were 
redissolved in 300 µl 75 % methanol. Further dilutions were made in water and the final methanol 
concentration varied from 4 to 9.5 %. The commercial ELISA was EnviroGard Microcystin Plate Kit 
(Strategic Diagnostics, Newark, DE). Manufacturer’s instructions were followed. 100 µl were added 
to the wells and the plate was incubated at room temperature for 30 min. The plate was washed 
four times with 5 mM Tris–HCl pH 7.8, 0.15 M NaCl, 0.05% Tween 20 and incubated for 30 min 
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after addition of 100 µl substrate. Stop solution was added and the plate was measured after 15 
min with a spectrophotometer at 450 nm.  
TR-FIA in paper II was conducted in the same manner as the commercial ELISA with the following 
exceptions. No stop solution was added and the microcystin-enzyme conjugate was replaced by 
MCLR-Eu (2 µg/l, 100 µl) and substrate by Enhancement Solution, 100 µl. The Enhancement 
Solution is an acidic proprietary detergent solution that dissociates Eu3+ from the bound Eu-
labelled microcystin and chelates it to form a highly fluorescent micelle (PerkinElmer, Turku, 
Finland). Measurement was conducted within 15 min after addition of Enhancement Solution with 
a time-resolved fluorometer.  
3.9  PROTEIN PHOSPHATASE INHIBITION 
In paper II a fluorimetric protein phosphatase inhibition method was modified from Fontal et al. 
and Gee et al. (Fontal et al., 1999; Gee et al., 1999). Heating the samples to 80°C for 15 min 
inactivated endogenic phosphatases. Protein phosphatase 1 (PP1) was diluted with TRIS buffer (50 
mM TRIS, 0.1 M EDTA, 0.2 mg/ml BSA, 5 mM ditiotreitol, pH 7) and 0.025 units of PP1 was 
incubated in each well for 10 min. Standards and samples were added and incubated with enzyme 
for 10 min. Substrate, DiFMUP, was added to a final concentration of 100 µM. After 1 h incubation, 
fluorescence was measured (exc. 355 nm, em. 460 nm) with a fluorometer.  
In paper V a colorimetric protein phosphatase inhibition assay protocol similar to that described by 
An and Carmichael (1994) was used. Samples and calibrators, dissolved in water, were added to 
microtiter plate wells together with 10 µl PP1 (activity of 1.67 U/ml, dissolved in buffer). The 
negative control contained only PP1. Substrate (15 mM p-NPP) was added and after two hours of 
incubation at 37°C the absorbance was measured at 405 nm on 1420 Victor multilabel counter 
(PerkinElmer, Turku, Finland). The assay was repeated three times with samples, calibrators and 
negative controls performed in duplicates. The inhibition percentages were calculated as: average 
(OD of calibrator 0 – average OD of standard or sample) × 100 / average OD of standard.  IC50 was 
calculated as the concentration of toxin that inhibited half of the protein phosphatase activity 
compared with the uninhibited control reaction.  
3.10 MODEL MEMBRANES  
3.10.1 Surface barostat technique 
The capacity of MC-LR, MC-LF and MC-LW to penetrate membranes was studied by the surface 
barostat technique in monolayers consisting of egg phophatidylcholine and cholesterol (7:3, molar 
ratio). Lipids dissolved in hexane/isopropanol (3:2, vol/vol) were spread on a sub-phase (Verger 
and Pattus, 1976) consisting of 20 mM Tris–HCl and 145 mM NaCl, pH 7 (Fig. 8). The toxins were 
injected in the subphase (final concentration of 1 mM) and the change in the surface pressure (Δπ) 
was registered with a platinum Wilhelmy plate (Fig. 8; (Bougis et al., 1981). Penetration of toxins 
into the lipid monolayer was determined at room temperature with a KSV 3000 surface barostat 
(KSV Instruments Ltd, Helsinki, Finland).  
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Figure 8. Schematic picture of a throug used in the surface barostat technique (KSV Nima, Espoo, 
Finland). Lipids are carefully spread on a sub-phase. The Wilhelmy plate registers the surface 
pressure and the monolayer can be compressed or expanded with the movable barrier. Picture 
drawn by the author, inspired by Verger and de Haas (1973) 
3.10.2 Steady-state fluorescence anisotropy 
Vesicles of egg phosphatidylcholine (100 mM) were made in a buffer containing 20 mM Tris–HCl 
and 145 mM NaCl. Unilamellar vesicles were prepared after brief sonication by repeated extrusion 
through 100 nm polycarbonate filters (Costar Corp., Cambridge, MA) using a Lipextruder (Lipex 
Biomembranes, Vancouver, BC) according to Hope et al. (1985). TMA-DPH, dissolved in ethanol, 
was added to the vesicles (final concentration 1 mole %). Anisotropy was measured in the 
presence and absence of microcystins (final concentration 1 mM). A PTI Quantamaster 1 
spectrofluorometer was used for the steady-state fluorescence anisotropy measurements with the 
software program Felix (Photon Technology International, Canada). After excitation at 360 nm, the 
emission was registered with two channels at 430 nm. The excitation polarizer was first placed in 
the vertical orientation, and the ratio of the parallel and perpendicular signals (RV) was measured. 
Then the ratio was measured using horizontally polarized excitation, both emission channels 
observing the emission (RH). These values, which include the system specific G factor, were used 
to calculate the anisotropy, r. 
3.10.3 Fluorescence emission maximum 
The fluorescence emission maximum of tryptophan in MC-LW (final concentration 7.5 mM) was 
measured after excitation at 280 nm in the presence and absence of egg phosphatidylcholine 
vesicles (final concentration 750 mM). The toxin was dissolved in buffer (20 mM Tris–HCl and 145 
mM NaCl, pH 7).  
3.10.4 Generalized polarization 
Lipid vesicles of DPPC were dissolved in a buffer of 20 mM Tris-HCl and 145 mM NaCl, pH 7. After 
sonication (duty cycle 40 %, output control 5) for 2 minutes with a Branson probe sonifier W-250 
(Branson Ultrasonics, Danbury, CT), unilamellar vesicles were prepared by repeated extrusion 
using a Lipextruder (Lipex Biomembranes, Vancouver, BC) through 100 nm polycarbonate filters 
(Costar Corp., Cambridge, MA) according to Hope et al. (1985). Laurdan (final concentration of 1 
mole%) was dissolved in ethanol and incorporated in the vesicles by shaking for 30 min. After 
excitation at 365 nm, laurdan emission spectra were recorded between 400 and 580 nm with a PTI 
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QuantaMaster 1 spectrofluorimeter (Photon Technology International, Lawrenceville, NJ). A 
temperature probe was submerged in the sample and the temperature (40°C) was controlled by a 
Peltier element. The generalized polarization (GP) was calculated according to 
GPex = 
𝐼440−𝐼475
𝐼440+ 𝐼475  
where I440 is the fluorescence intensity at 440 nm, the characteristic wavelength of the liquid 
disordered phase, and, I475 is the emission intensity at 475 nm, the characteristic wavelength of the 
liquid ordered phase (Parasassi et al., 1990). The emission spectra of Laurdan was measured and 
compared in the absence and presence of toxins (1 and 10 µM final concentration). Tamoxifen was 
used as a successful positive control (Engelke et al., 2001). 
3.10.5 Fluorescence resonance energy transfer 
Lipid vesicles were made of POPC and CTL (molar ratio 99:1) by probe sonication. The phospholipid 
was dried under argon at 40°C with excess solvent removed by vacuum drying for 20 min, and 
resuspended in argon-purged Tris-HCl buffer. CTL was added and the lipids were briefly vortexed 
and sonicated (duty cycle 20 %, output control 5) for 2 min using a Branson W-250 probe sonifier 
(Branson Ultrasonics, MA, USA). After excitation at 290 nm the fluorescence emission intensity of 
CTL was measured at 374 nm using PTI QuantaMaster-1 spectrofluorimeter (Photon Technology 
International, Lawrenceville, NJ). The intensity of the fluorescence emission was compared in the 
absence and presence of MC-LW (5 µM final concentration).  
3.11 CACO-2 CELL LINE CULTURE 
Caco-2 cells (human epithelial colorectal adenocarcinoma cells, DSMZ, Braunschweig, Germany) 
were grown at 37°C in a humidified atmosphere (5 % CO2, 95 % O2) in plastic dishes in Dulbecco’s 
modified Eagle medium supplemented with 10 % Fetal Calf Serum, 1 % L-glutamine, 100 U/ml 
penicillin and 100 µg/ml streptomycin. After trypsinization, staining with trypan blue and counting 
using a cell haemocytometer (Neubauer improved, Marienfeld, Germany) the cells were seeded 
the day before the start of the cell proliferation and cytotoxicity assays in 96-well microtiter plates 
(BD Falcon, Helsinki, Finland) at densities of 80000 cells/ml. Fresh media was added to all wells at 
the start of the experiments. Control cells were treated with 5 µl pure PBS and the experiment 
cells with 5 µl of each toxin dissolved in PBS (final toxin concentration 1, 10 or 50 µM), every 
concentration was run at least in triplicates. 
3.11.1 Cell viability and morphology 
To study the effects of microcystins on Caco-2 cell morphology, cells were exposed to MC-LR, MC-
LW and MC-LF at 50 µM for 22 h and 44 h, and photographed under phase contrast in a Leica DMIL 
light microscope using a Leica EC3 digital camera.  
3.11.2 Cell proliferation 
The effects of microcystins on Caco-2 cell proliferation were studied with the Cell Proliferation 
Reagent WST-1 (Roche Applied Sciences, Mannheim, Germany). Mitochondrial dehydrogenases 
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catalyse the cleavage of tetrazolium salt WST-1 to dark red formazan (Berridge et al., 2005). An 
increase of viable and metabolically active cells leads to increased mitochondrial dehydrogenases 
and increased cleavage of formazan. Cells treated in 96-well microtiter plates with MC-LR, MC-LW 
and MC-LF were compared to non-treated cells and controls, according to the WST-1 kit 
description. The amount of formazan dye formed was measured on a multiwell 
spectrophotometer (Varioskan Flash, Thermo Fisher Scientific Inc, Vantaa, Finland) at 450 nm after 
the addition of 10 µl of Cell Proliferation Reagent WST-1.  
3.11.3 Cytotoxicity assay 
Damage on the cell membrane was estimated by lactate dehydrogenase (LDH) leakage using a 
Cytotoxicity Detection Kit (Roche Applied Sciences, Mannheim, Germany). The test was performed 
according to the LDH assay protocol. The reaction mixture provided with the kit was added to all 
wells to monitor the leakage of LDH into the extracellular fluid. A lysis solution was added to the 
high control wells for the maximum cellular amount of LDH. Cells that were not treated with toxins 
represent the spontaneous baseline leakage of LDH. The % LDH leakage from cells treated with 
MC-LR, MC-LW and MC-LF was calculated from the maximum cellular LDH leakage.  
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4 RESULTS AND DISCUSSION 
4.1 DEVELOPMENT OF TR-FIA (I) 
4.1.1 Labelling of microcystin with europium 
The use of lanthanides in immunoassays requires a chelating group that binds the lanthanide ion 
and a functional group for the attachment to biomolecules (Soini and Hemmilä, 1979; Hagan and 
Zuchner, 2011). There is a wide variety of different chelators for constructing lanthanide chelates 
to be used in time-resolved fluoroimmunoassays (Hagan and Zuchner, 2011). The DELFIA system 
developed by PerkinElmer uses the major class of non-luminiscent polyaminocarboxylates that 
carry the lanthanide as a tag (Soini and Hemmilä, 1979; Soini and Kojola, 1983; Lövgren et al., 
1984). The labelling reagent chosen here was an isothiocyanate derivative of the stable europium 
chelate that reacts readily with e.g. amino groups (Mathis and Bazin, 2011). A free amino group 
was therefore first introduced to MC-LR. After derivatisation with 2-aminoethanethiol, the 
product, MCLR-aminoethanethiol (MCLR-AET), was purified from MC-LR according to the retention 
time, 9.37 min for MCLR-AET versus 17.4 min for MC-LR, on HPLC (Fig. 9).  
 
Figure 9. Separation of MC-LR and MCLR-AET on a Nucleosil 100 5 C18 column, 250 mm×4 mm i.d.. 
Mobile phase: solvent A (27% acetonitrile and 73% 13.5 mM ammoniumacetate) and B (80% 
acetonitrile and 20% 13.5 mM ammoniumacetate) with the following linear gradient programme: 0 
min concentration of B was 0%, 12 min 0% B, 30 min 25% B, 32 min 25% B and 34 min 0% B. 
Detection wavelength 238 nm. Flow rate 1 ml/min, total run time 35 min. 
MCLR-AET with the free amino group was then linked to the europium chelate. Efficient labelling 
(about 70%) was reached and MC-LR conjugated to the Eu chelate (retention time 27.93 min) was 
easily separated from non conjugated MC-LR (36.97 min) with HPLC (Fig. 10). The Eu chelate 
increased the molecular weight of the final product from 994 Da to 1700 Da. The product also 
became more hydrophilic. As the principal chromophore, the conjugated diene in Adda, was not 
modified, the same molar absorptivity factor that was used for MC-LR (ε=39810) was used for the 
conjugated product.  
MCLR-AET 
MC-LR 
 
Retention time, min 
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Figure 10. Separation of MCLR-AET and MCLR-Eu chelate on a Nucleosil 100 7 C18 column, 
250 mm×10 mm i.d. Mobile phase: solvent A (2 volumes of water and 1 volume of solvent B) and B 
(27% acetonitrile and 73% 13.5 mM ammonium acetate) with the following linear gradient 
programme: 0 min 0% B, 20 min 100% B, 45 min 100% B and 50 min 0% B. Detection wavelength 
238 nm. Flow rate was 2 ml/min and total run time was 51 min. 
4.1.2 TR-FIA in detection of microcystins  
The efficacy of TR-FIA as an analytical method for microcystins was evaluated. Pure MC-LR and a 
cyanobacterial extract were analyzed in parallel by using TR-FIA and HPLC. The concentration of 
purified MC-LR was determined by HPLC and dilutions were made for TR-FIA. A typical sigmoidal 
standard curve was obtained with TR-FIA for MC-LR concentrations of 0.01-50 μg/l (Fig. 11, black 
squares). Standard deviation was low (±2.7%, max 6%), calculated as average of three replicates 
for each concentration. 
 
Figure 11. TR-FIA standard curve for MC-LR concentrations 0.01-50 µg/l (black squares). TR-FIA 
response curve for Anabaena sp. 90 extract (white squares). All values are average of three 
replicates.  
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Environmental samples usually contain several different microcystins. The performance of TR-FIA 
was tested by analyzing an extract of Anabaena sp. 90, that produced four different microcystins. 
Toxin variants in Anabaena sp. 90 had been determined by others (Rapala et al. 1997) and were 
verified by us with mass spectrometry and amino acid analysis (results not shown). The methanolic 
extract of Anabaena sp. 90 was analyzed with HPLC and contained 16 μg/ml MC-LR (retention time 
19.05 min), 11 μg/ml MC-RR (21.73 min), 8 μg/ml [D-Asp3]-MC-LR (22.32 min) and 5 μg/ml [D-
Asp3]-MC-RR (21.11 min), i.e. the total content of microcystins was 40 μg per ml (Fig. 12). MC-LR 
constituted 40% of the total microcystin amount. The extract was diluted into water and used as a 
representative of an environmental sample. Since the WHO guideline value for microcystin-LR is 
given in µg per litre water the same unit was chosen here. 
 
Figure 12. Separation of microcystins in Anabaena sp. 90 on a Nucleosil 100 3 C18 column, 
150 mm×2 mm i.d. Mobile phase: solution A (20% acetonitrile and 80% 13.5 mM ammonium 
acetate) and B (100% acetonitrile), with the following linear gradient programme: 0 min 0% B, 
30 min 20% B, 32 min 20% B and 34 min 0% B. Flow rate 0.2 ml/min and total run time 51 min. 
The Anabaena extract was diluted to fit to the concentration range of the TR-FIA standard curve. 
The response curve of the Anabaena extract matched the standard curve of pure MC-LR (Fig. 11). 
Therefore it was concluded that an estimation of microcystins in environmental samples can be 
done by comparing the result to a standard curve of pure MC-LR.  
Depending on which analytical method was chosen for the detection of microcystins different 
aspects needed to be considered. TR-FIA was suitable for screening purposes, while HPLC was 
conducted for the identification and quantification of microcystin variants. Although the WHO 
guideline specifically refers to MC-LR, it is of importance to analyze the total amount of 
microcystins. That includes all microcystin variants in the sample. Antibodies used in TR-FIA cross-
reacted with structurally similar molecules, i.e. other microcystin variants. Analyzing total amount 
of microcystins with HPLC required standards. The standards available were MC-LR, MC-RR, MC-
YR, MC-LY, MC-LF, MC-LW, dmMC-LR, dmMC-RR, didmMC-LR. Moreover, HPLC usually required a 
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time-consuming pretreatment of the sample due to e.g. higher detection limit and cleanup needs, 
while untreated water samples could be analyzed with TR-FIA.  
4.1.3 TR-FIA versus ELISA  
TR-FIA was compared, with respect to detection limits, to a commercially available ELISA kit (SDI 
EnviroGard ELISA, Strategic Diagnostics Inc, Newark, DE). A higher level of sensitivity was reached 
with TR-FIA compared to ELISA when using the antibodies and assay conditions optimized for the 
commercial ELISA. The lowest concentration used (100 pg/ml) showed a decrease in the 
fluorescence of TR-FIA that was statistically different from the negative control (Fig. 13). TR-FIA 
was shown to be a useful technique for screening microcystins in water. The response curve in TR-
FIA was more even and more smooth at low concentrations (Fig. 13). The sensitivity of TR-FIA 
using Eu chelates has been found to be higher compared to ELISA, e.g. Siitari showed a 30-60-fold 
increase in sensitivity (Siitari, 1990). Several other studies have shown increased sensitivities with 
time-resolved fluorescence assays compared to conventional ELISA (Ogata et al., 1992 ; Allicotti et 
al., 2003; Butcher et al., 2003). Detection limits for different non-radioactive labelling systems 
were summarized in Diamandis, 1990. For conventional enzyme markers the detection limit was 
10−10–10−11 mol/l, and the lowest detection limit was seen with europium chelates in TR-FIA, 10−12–
10−13 mol/l (Diamandis, 1990). In TR-FIA a higher sensitivity has been reached also when using 
smaller sample volumes, allowing assay minituarization development (Daijo and Sportsman, 1999; 
Lavery et al., 2001 ; Zuck et al., 2005). Smaller sample volumes allow larger dilutions with e.g. 
buffers used in the assay and matrix effects can thereby be eliminated more efficiently (Peruski et 
al., 2002).   
Figure 13. Concentration curve of TR-FIA (squares) and ELISA (dashed line). % Binding was 
calculated as the mean fluorescence/absorbance of each concentration (B) divided with the mean 
zero standard value (B0). All values are average of three replicates. 
The total analysis time was decreased from 1½ h to 1 h using TR-FIA, since the last incubation step 
in ELISA (addition of a stop solution) is not required in TR-FIA. In screening purposes savings in 
time are of interest (Munoz-Olivas, 2004). Several ELISA kits that are commercially available for 
microcystin analysis use colorimetric detection of the signal produced by HRP together with its 
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substrate, e.g. EnviroLogix QuantiPlate Kit for Microcystins, Abraxis Microcystins-ADDA ELISA and 
Envirogard Microcystins QuantiTube Test Kit. Change of color intensity is easy to detect and often 
precise enough for most analysis. However, the detection method is restricted by several 
characteristics of HRP and colorimetry (Gosling, 1990). HRP is easily inactivated and sensitive to 
several inhibitors, even though well preserved enzyme conjugates usually stay intact for several 
years. Europium chelates on the other hand have been shown to have a long-term stability. The 
lanthanide chelates are easy to handle and not sensitive to temperature or light (Sevéus et al., 
1994). 
HRP has complicated kinetics and it can be inhibited by high substrate concentrations. In 
colorimetry the intensity of the monochromatic light that has not been absorbed by the sample is 
measured, which means that at low concentrations small differences in intensity must be 
measured and this demands a high light intensity which in turn limits the detection level. In the 
colorimetric detection of ELISA, the optical absorbance measurements allow a pretty narrow 
dynamic scale. A wider dynamic range has been reached when using TR-FIA (Peruski et al., 2002). A 
considerably broader range was shown in one publication where a scale of 2 – 160000 ng/l was 
reached (Madersbacher et al., 1993). That would reduce multiple dilution steps and 
remeasurement of samples when concentrations fall outside the range of the standard curve. The 
unique fluorescent properties of lanthanide chelates allow sensitive and specific detection of an 
analyte. Europium, the most used lanthanide, can form highly fluorescent chelates which have a 
long fluorescence lifetime and a large Stokes’ shift.  
4.2 PREVALENCE OF MICROCYSTINS ON THE ÅLAND ISLAND (II, III) 
During the years 1999-2001 samples from practically every fresh water lake on the Åland Islands 
were analysed for microcystins and nodularins (Table 3 and 4). Microcystins were analysed by 
HPLC, PPIA and TR-FIA. Surveys covering such a high local area are quite rare. A large variety of 
lake types exist on the Åland mainland and on the larger islands of the Åland archipelago 
(Lindholm, 1996). Several lakes and drinking water reservoirs have a history of toxic cyanobacteria 
occurrence (Lindholm et al., 1989; Lindholm and Eriksson, 1990; Lindholm et al., 1999). The 
summer 1999 was sunny and visible cyanobacteria blooms were observed in approximately half of 
the 55 examined lakes, of which 4 contained microcystins, determined by HPLC. In summer 2000 
several lakes in forest areas were included and cyanobacterial blooms were found in 40 lakes of 
134 lakes analysed. Microcystins were found in 14 lakes. Especially the eutrophic lakes contained 
microcystins but also in some dystrophic lakes and even in one oligotrophic lake, microcystins 
were found. One of the lakes was a drinking water reservoir, Tjudö träsk, and several other lakes 
were used for crop irrigation.   
Satisfactory correlations were achieved in 2000 with the three analytical methods, TR-FIA, PPIA 
and HPLC (Table 3). In one lake, Träsket, microcystins was detected only with HPLC, although HPLC 
had the highest detection limit of 0.25 µg microcystin per litre water. For six other lakes 
microcystins were detected only with TR-FIA and/or PPIA. The reason why microcystins were not 
detected with HPLC could be the limited number of available standards or that several minor 
microcystin variants were present but below the detection limit. In three cases there were 
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disagreements between TR-FIA and PPIA. The positive response obtained with TR-FIA (Glosholm 
lake, 11.9.2000) but not with HPLC or PPIA may be related to the dominating presence of the 
cyanobacterium Chroococcus. The cyanobacterium Chroococcus is not a known microcystin 
producer but could have produced other compounds that cross-reacted with the antibodies in TR-
FIA. The positive responses obtained only with PPIA (Gesterby tjärnan 25.8.2000 and 
Bokhällamossen 6.9.2000) could have been due to the presence of other protein phosphatase 
inhibitors than microcystins. E.g. oscillamides and anabaenopeptins are protein phosphatase 
inhibitors as well, and produced by cyanobacteria (Harada et al., 1995; Sano et al., 2001). Toxins of 
non-cyanobacterial origin, like okadaic acid, tautomycin and calyculin A, have also been shown to 
have protein phosphatase inhibition capacity (Bagu et al., 1997). In several lakes the 
cyanobacterial bloom lasted until late autumn, as for example in Nåtö Hemviken where 
microcystins were found in every collected sample. The highest microcystin level, 12 µg/l, was 
detected with PPIA in Nåtö Hemviken in October 2000. Several different species of Microcystis 
were present at that time in the lake. However, microcystins were not detected with HPLC, at least 
not with the available standards. TR-FIA showed a microcystin concentration of 7.2 µg/l. The high 
concentration detected with PPIA suggested that compounds that inhibit protein phosphatase 1, 
both microcystins and others, might have been present in the lake.  
Based on microscopic examination of the samples collected 1999-2000, the most likely microcystin 
producers in the lakes were Planktothrix agardhii, Microcystis aeruginosa and Anabaena 
lemmermannii. Annual variations seemed to be common as none of the four positive lakes in 1999 
had any microcystins detected the next year, although samples were taken at nine different 
occasions from e.g. Östra Kyrksundet (Lindholm et al., 2002). Different cyanobacteria showed a 
tendency to dominate on an annual basis. Mass occurrence of Planktothrix agardhii was detected 
in lake water samples from Vargsundet in the year 1997 and Microcystis aeruginosa in the year 
2000 (Lindholm et al., 1999). 
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Table 3. Microcystins (µg/l) detected on the Åland Islands in 1999 and 2000.  
nd stands for “not detected”. 
 
 
 
 
 
 
 
 
 
 
 
 
 
In 2001, 93 lakes on the Åland Islands were analysed (113 water samples) for microcystins and 
nodularins. Three different methods, ELISA, HPLC-UV and LC-MS, were compared and the results 
were shown to be comparable (Table 4). Microcystin concentrations exceeding 0.2 µg/l were 
detected with at least one technique in 31 water samples (16 different lakes) and with all three 
techniques in 21 water samples (9 lakes). The sum of the total microcystin concentrations in the 
positive samples was 179 µg/l for HPLC-UV, 200 µg/l for LC-MS and 135 µg/l for ELISA (Table 4). 
The lowest concentrations were often seen with ELISA. The antibody cross-reactivity towards 
different microcystin variants is known to vary. The cross-reactivity in the commercial ELISA used 
for the analysis was relatively equal for the few microcystin variants that had been tested, with 
EC50 values for MC-LR 0.31 µg/l, MC-RR 0.32 µg/l and MC-YR 0.38 µg/l. The cross-reactivity for 
other variants, such as demethylated microcystins, had not been reported.  
The microcystins most often found were MC-RR, -LR and -YR with different degrees of 
demethylation. The more hydrophobic variants, MC-LF and MC-LY, occurred in only one case, 
Katthavet. The highest microcystin concentration according to ELISA was 30 µg/l (Vargata lake, 
August). The same sample also showed the highest concentration detected with HPLC-UV 42 µg/l 
and with LC-MS 39 µg/l. The lake Prästträsket in June showed according to LC-MS the highest 
microcystin concentration 42 µg/l whereas HPLC-UV detected 34 µg/l and ELISA 16 µg/l. When the 
Date Location HPLC TR-FIA PPIA 
7.9.1999 Östra Kyrksundet 6.4 
N
ot exam
ined 
N
ot exam
ined 
19.9.1999 Gloskärs träsk 2.2 
22.9.1999 Långsjön 1 
30.9.1999 Syllöda träsk 5.8 
28.6.2000 Brantsböle träsk nd 1.6 0.5 
29.6.2000 Nåtö Hemviken nd 7.2 12 
5.7.2000 Tjudö träsk 4.7 5 8 
6.7.2000 Olofsnäs 1.3 1 0.3 
3.8.2000 Prästträsket 5.7 4 4.5 
18.8.2000 Lemböte Byträsk 5.1 3 6 
25.8.2000 Gesterby tjärnan nd nd 0.5 
3.9.2000 Godby träsk nd 0.4 0.3 
6.9.2000 Bokhällamossen nd nd 1.4 
11.9.2000 Glosholms träsk nd 0.6 nd 
18.9.2000 Träsket 1.4 nd nd 
18.9.2000 Vargata träsk 0.7 0.8 2 
22.9.2000 Vargsundet 0.4 0.3 0.2 
6.11.2000 Strömma träsk 1.3 1.1 2.8 
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sample was collected, Planktothrix agardhii dominated. A month later the concentrations had 
decreased to 3.4, 3.1 and 3.0 µg/l respectively according to LC-MS, HPLC-UV and ELISA. The 
discrepancy at the higher concentrations could be related to the high presence of demethylated 
variants. Depending on the cross-reactivity ELISA can over- or underestimate the concentration of 
microcystins in a sample (Gago-Martinez, 2007). Usually antibodies used in ELISA have been raised 
against a specific microcystin variant and therefore cross-reactivity against other variants might be 
considerably lower (Fischer et al., 2001). When a sample contains microcystin variants not 
particularly well recognised by the antibodies, immunoassays tend to underestimate the 
microcystin concentration.  
In paper II TR-FIA was compared to HPLC and PPIA (2000) and in paper III to ELISA, HPLC-UV and 
LC-MS (2001). All the methods used were found to be useful for real water samples. The best 
agreement between different detection methods was shown with samples that mainly contained 
MC-LR and/or MC-YR. The half maximum inhibition concentration (IC50) for those variants 
together with MC-RR has often been reported when antibodies have been developed for 
immunoassays (Chu, 2000). More seldom have IC50 values been determined for demethylated 
microcystin variants (Fischer et al., 2001).  
Parallel methods to analyze microcystins have been used in several publications, either to directly 
compare and evaluate the methods or to combine fast screening with variant analysis (Rapala et 
al., 2002; Muñiz Ortea et al., 2004; Gkelis et al., 2005; Mountfort et al., 2005). ELISA and protein 
phosphatase inhibition assay (PPIA) were used in parallel to estimate the concentration of 
microcystins with an intention to evaluate the toxicity of the microcystins (Carmichael and An, 
1999; Mountfort et al., 2005). Rapala et al. (2002) showed that protein phosphatase inhibition 
assay, ELISA and HPLC correlated well when analysing pure toxin, laboratory cultures, water 
samples and cyanobacterial samples for several microcystin variants. However, [D-Asp3]-
microcystins and hydrophobic microcystins constituted exceptions.  
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Table 4. Occurence of microcystins (µg/l) on Åland Islands 2001 (nd = not detected).  
The ELISA results are reported in MC-LR equivalents. 
 
 
Location Date HPLC-UV LC-MS-SIR ELISA Detected MC variants 
Baststjärnan June 18 0.13 0.34 nd LR, RR, dmLR, dmRR 
Brantsböle träsk June 1 0.26 0.47 0.5 LR, RR, dmLR 
Brantsböle träsk June 27 0.86 1 0.4 LR, YR, dmLR 
Brantsböle träsk June 27 0.62 0.49 0.4 LR, YR, dmLR 
Brantsböle träsk June 27 0.67 0.74 0.4 LR, YR, dmLR 
Brantsböle träsk Aug. 9 3.1 1.4 1.5 LR, YR, dmLR 
Brantsböle träsk Oct. 7 0.21 0.37 0.1 LR, YR, dmLR 
Gloskärs träsk June 26 0.2 0.1 0.1 LR, YR, dmLR 
Gloskärs träsk June 26 0.25 0.11 0.1 LR, YR, dmLR 
Godby träsk June 7 1.4 0.48 0.2 LR, RR, dmRR 
Godby träsk July14 5.1 3.6 4.8 LR, RR, dmRR 
Hägnträsk Aug. 8 0.44 <0.10 nd RR, YR, dmLR 
Högbolstad June 6 0.07 0.22 0.15 RR, dmRR 
Kaldersfjärden June 28 0.7 <0.10 0.1 RR, YR, dmRR, dmLR 
Katthavet July 30 1.7 1.8 0.9 LR, LF, LY 
Lemböte Byträsk July 6 2.3 3.5 3 LR, YR, dmLR 
Lemböte Byträsk July 21 6 8.1 4 LR, YR, dmLR 
Lillfjärden July 29 0.16 0.21 0.1 LR, dmLR 
Norra Långsjön July 23 0.1 0.12 0.2 LR, dmLR, nod 
Nåtö Hemviken June 25 6.4 7.4 7.6 LR, RR, YR 
Prästträsket June 7 12.1 25.7 8 LR, RR, dmLR, dmRR, didmRR 
Prästträsket June 29 33.9 42 16 LR, RR, YR, dmRR, didmRR 
Prästträsket July 30 3.1 3.4 3 LR, RR, YR 
Prästträsket Aug. 9 7.5 8.5 9.1 LR, RR, YR 
Strömma träsk June 28 1 1.5 0.8 RR, dmRR, didmRR 
Strömma träsk Oct. 7 nd <0.10 0.3 dmLR, dmRR, didmRR 
Vargata träsk July 13 5.4 3.9 6.8 LR, RR, YR 
Vargata träsk July 17 4.6 4.7 4.8 LR, RR, YR 
Vargata träsk, NE Aug. 9 36.8 32.8 30 LR, RR, YR 
Vargata träsk, SW Aug. 9 42.3 38.6 30 LR, RR, YR 
Överby insjö July 24 0.94 0.97 0.5 LR, dmLR 
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4.3 INTERACTION OF MICROCYSTINS WITH MEMBRANES AND CELLS (IV, V) 
4.3.1 Microcystin interaction with monolayers (IV) 
The membrane penetrating capacity of MC-LR, MC-LW and MC-LF was studied by the surface 
barostat technique in monolayers at various initial pressures and at constant area. The toxins were 
injected beneath the monolayer film (in the subphase) and the surface pressure was observed. The 
penetration capacity, or the surface activity, of MC-LR was low using artificial monolayer 
membranes made of egg phosphatidylcholine:cholesterol (molar ratio 7:3). MC-LR did not cause 
an increase in the membrane surface pressure at initial pressures between 9 and 26 mN/m (Fig. 
14). However, the more hydrophobic microcystins, MC-LW and MC-LF, showed clear surface 
pressure dependent membrane penetrating capacities, as indicated by their effect on the 
monolayer surface pressure. MC-LW and especially MC-LF, induced a rapid increase in the surface 
pressure. The packing density in the monolayer was increased by the presence of toxins as the 
surface area available for the monolayer was not allowed to expand, and this was reflected as an 
increased surface pressure (Phillips and Krebs, 1986). Extrapolating their linear relationship of the 
surface pressure change versus initial surface pressure to Δπ=0 gave exclusion pressures of 21.3 
mN/m for MC-LF and 22.9 mN/m for MC-LW (Fig. 14).  
 
 
 
Figure 14. Interaction of microcystins with monolayers as studied by  
the surface barostat technique. Microcystins were injected in the subphase  
beneath the lipid monolayer and the change in surface pressure was monitored  
as the monolayer area available was not allowed to change. 
 
The physiological pressure in biomembranes is close to 30 mN/m (Marsh, 1996) and considering 
the exclusion pressure of 21.3 mN/m for MC-LF and 22.9 mN/m for MC-LW no spontaneous 
penetration is likely to occur. However, the surface pressure of biomembranes can fluctuate ±15 
mN/m due to compressibility properties of the membranes (Phillips et al., 1975). Thereby, it might 
be possible that membranes with packing defects could be more affected by the more 
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hydrophobic toxins. Evidence of membrane effects of MC-YR was found in a study by Lankoff and 
Kolataj (Lankoff and Kolataj, 2001). The authors showed that MC-YR caused a destabilisation of 
lysosomal membranes. MC-LF and MC-LW, being more hydrophobic, could perhaps give rise to an 
even more pronounced effect on the membranes. In paper IV it was shown that there are 
differences in how hydrophilic and hydrophobic microcystins interact with lipid membranes. These 
differences could have an effect on the organotropism, toxicokinetics and bioaccumulation of 
microcystins. Microcystins are considered to need the OATP system for entering the cell (Fischer et 
al., 2010). However, virtually all eukaryotic cells internalize pieces of their plasma membrane 
through pinocytosis. If some (hydrophobic) microcystins would be associated with the plasma 
membrane these toxins could more readily enter the cell. Bacteria are known to produce toxins 
that enter the cell through e.g. internalization (Montecucco et al., 1994; Montecucco, 1998). 
Possible non-specific uptake of different microcystin variants in the endocytotic pathway deserves 
some attention in the future. 
4.3.2 Steady-state fluorescence anisotropy studied by TMA-DPH (IV) 
The membrane fluidity was measured using TMA-DPH as a probe located in the membrane 
interface. An anisotropy value of 0.190 for pure phosphatidylcholine vesicles was achieved (Fig. 
15). Anisotropy is a dimensionless quantity with a maximum value of about 0.4 due to unoriented 
samples and the angular dependence of photoselection. Addition of the different microcystins to a 
final concentration of 1 mM decreased the calculated anisotropy value to 0.170 for MC-LR and to 
0.163 for MC-LW and MC-LF (Fig. 15). A decreased anisotropy correlates to increased rotational 
freedom of the probe. Since all three toxins decreased TMA-DPH anisotropy similarly and MC-LR is 
not likely to affect membrane packing, as shown in the monolayer experiments, it appeared that 
the toxins directly affected the anisotropy of TMA-DPH in the membrane, perhaps by altering the 
hydrogen bonding network at the water/membrane interface.  
 
 
 
Figure 15. Steady-state fluorescence anisotropy of TMA-DPH. Microcystins were added to  
the vesicle solution and the fluorescence of TMA-DPH was measured in the absence and  
presence of microcystins, whereupon the anisotropy was calculated.  
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Steady-state fluorescence anisotropy was used to achieve information about the membrane 
environment around the fluorescent probe, TMA-DPH. When exciting the fluorophore with 
polarized light the emission is expected to be polarized. Rotational diffusion of the fluorophore can 
depolarize the emission. The extent of depolarization is described in terms of anisotropy. 
Membrane-bound fluorophores are able to reveal the internal viscosity of the membrane and 
whether the lipid composition is affected. Fluorescence anisotropy of the nonpolar fluorescent 
probe 1,6-diphenyl-1,3,5-hexatriene (DPH) has been used by Hermansky and Stohs to investigate 
fluidity in microsomal membranes in presence of MC-LR but no alterations in the membrane 
fluidity was observed (Hermansky and Stohs, 1991). By using TMA-DPH that partitions into the 
water/membrane interface, and egg phosphatidylcholine vesicles, a statistically significant 
decrease in fluorescence anisotropy could be observed when microcystins were present (Fig. 15).  
4.3.3  Fluorescence emission maximum (IV) 
MC-LW with the intrinsic fluorophore in the indole group of tryptophan was used in the steady-
state fluorescence emission maximum experiments. The indole group in tryptophan has an 
emission spectrum that is dependent on the polarity of the local environment. The 
microenvironment around the tryptophan in the aqueous solvent changed when lipid vesicles 
were added. When comparing the fluorescence emission spectra recorded for MC-LW in the 
presence and absence of vesicles, an increased blue shift of the spectra in the presence of vesicle 
membranes was revealed (Fig. 16). This implied that the tryptophan in MC-LW translocated into a 
more hydrophobic environment as the toxin was allowed to interact with the bilayer membrane.  
 
 
 
 
Figure 16. Fluorescence emission spectra of tryptophan in MC-LW in the presence  
and absence of vesicles. MC-LW was injected into the vesicle solution and the 
 fluorescence emission spectrum was recorded after excitation at 280 nm. 
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4.3.4 Laurdan emission spectra (V) 
Generalised polarisation (GP) values for Laurdan incorporated in DPPC bilayers in the presence and 
absence of toxins were calculated and the emission spectra were analyzed. The GP values were 
not influenced and the relative proportion of the two phases that DPPC show at the chosen 
temperature was not shifted in the presence of microcystins. DPPC have at 40°C two co-existing 
phases, liquid ordered and liquid disordered phases. If some of the phases had been stabilized by 
addition of a microcystin it could have been indicated by the fluorescence emission profile of the 
incorporated fluorophore Laurdan as the spectral properties of Laurdan are altered in response to 
lipid packing (Parasassi et al., 1990). The emission profile was not shifted and the emission 
intensity was not changed. None of the microcystin variants, added externally to the DPPC 
vesicles, had any observable effect studied by this technique on the phase behaviour of the bilayer 
lipids. 
A single, well-studied phospholipid, DPPC, was preferred here due to its appropriate 
characteristics. The order of the hydrocarbon chains in a DPPC bilayer are decreased by high 
temperature due to the increased lateral and rotational motions of the lipid molecules (Purdon et 
al., 1976). To study whether the physical order of a vesicle bilayer is changed by microcystins, 
Laurdan was chosen as the fluorescent probe. Laurdan has an equal distribution in the liquid 
ordered and the liquid disordered phases that co-exist in DPPC vesicles at 40°C (Bagatolli, 2006). 
Laurdan, incorporated in vesicle membranes, can reflect the relaxation rate of water molecules 
present at the interfacial region of the membrane bilayer (Bagatolli, 2006).  
4.3.5 Resonance energy transfer (V) 
In an attempt to try to elucidate the location of tryptophan in MC-LW in relation to an 
incorporated sterol, CTL, in bilayers, resonance energy transfer measurements were performed. 
After excitation at 290 nm the emission intensity was measured at 374 nm. Although a good 
spectral overlap between the emission of tryptophan and the absorption of cholestatrienol was 
predicted (Holt et al., 2008), the emission intensity did not increase. It was concluded that energy 
transfer between the two fluorophores is not likely to occur. 
Resonance energy transfer can occur if there is a spectral overlap of the emission spectrum of a 
donor with the absorption spectrum of an acceptor, provided that also other criteria are met, e.g. 
the distance between the two molecules and the orientation of the molecules (Clegg, 1995). The 
tryptophan in MC-LW was used as the intrinsic fluorescent donor since it is able to transfer energy 
in its excited state to another chromophore (Lakowicz, 1999). The fluorescent probe CTL located in 
the membrane interface acted as the acceptor (Holt et al., 2008). Cholestatrienol is a fluorescent 
analogue of cholesterol and partitions in the vesicle membrane much like cholesterol do 
(Schroeder et al., 1988).  
4.3.6 Caco-2 cell viability and morphology (V) 
Morphological changes in Caco-2 cells were investigated and compared for MC-LR, MC-LF and MC-
LW. Morphological examination of Caco-2 cells exposed to microcystins revealed remarkable 
differences between different microcystin analogues. Cells exposed to relatively high 
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concentrations of MC-LR (50 µM) did not show changes in cell morphology after 22 h and 44 h of 
treatment, and resembled unaffected control cells (Fig. 17). On the other hand, cells treated with 
MC-LW and especially MC-LF, showed clear morphological alterations including apoptotic features 
with shrinkage, blebbing and loss of cell contact (Fig. 17). These changes appeared in a time and 
dose dependent manner (not shown). All three toxin variants changed the spreading of cells with 
minor effects by MC-LR, and a severe loss of cell number and cell-cell adhesion by MC-LF. 
Furthermore, blebbing was particularly evident for MC-LF.  
 
Figure 17. Morphological effects of microcystins in Caco-2 cells. Phase contrast microscopy images 
of Caco-2 cells after treatment with 50 µM microcystin for 22 h and 44 hours: MC-LR (b), MC-LW (c) 
and MC-LF (d). The control cells were treated with PBS (a). Scale bar is 100 µm. 
 
4.3.7 Caco-2 cell proliferation and cytotoxicity (V) 
To estimate plasma membrane damage, leakage of LDH was measured from Caco-2 cells treated 
with 50 µM toxins for 48 hours. Caco-2 cells not treated with toxins released spontaneously the 
same amount of LDH as MC-LR, about 22% of total cellular LDH (Fig. 18). Treatment with MC-LW 
and MC-LF caused an increased release of LDH, 45% and 52%, respectively, which was statistically 
significant (p ≤ 0.05, t-test) from controls and MC-LR treated Caco-2 cells (Fig. 18). The % of LDH 
released from cells treated with toxins was calculated from the maximum cellular LDH. Lactate 
dehydrogenase is a stable cytoplasmic enzyme present in all cells. When the plasma membrane is 
damaged, LDH is rapidly released into the cell culture supernatant (Korzeniewski and Callewaert, 
1983). MC-LW and MC-LF showed an increase in the LDH activity indicating a loss of plasma 
membrane integrity of the exposed cells. 
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Figure 18. LDH leakage in Caco-2 cells after exposure to 50 µM of MC-LR, MC-LW and MC-LF. 
Control cells represent the spontaneous leakage.  %LDH leakage was calculated from  
the maximum cellular LDH leakage. Values are mean ± standard deviation of four wells each. Data 
shown is a representative of 3 individually performed experiments. 
 
A toxin concentration of 50 µM did not affect the activity of mitochondrial dehydrogenases for 
MC-LR, but reduced it to 45% for MC-LW and 19% for MC-LF after 48 hour toxin exposure 
compared to the control (Fig. 19). At a toxin concentration of 10 µM the activity was reduced to a 
lesser extent, 87% for MC-LW and 75% for MC-LF, compared to the control (Fig. 19). At 1 µM, cell 
proliferation was not affected by any of the microcystins tested.  
In this experimental setup, the striking effects of MC-LR on Caco-2 cells that Botha et al. (2004) 
described were not observed (Botha et al., 2004). The culture conditions for Caco-2 cells have an 
effect on both morphology and the carrier-mediated transporters of the cells (Behrens and Kissel, 
2003). Here a higher concentration of cells was used and the toxins were added at a time when 
cells had already formed a stable monolayer, i.e. one day after seeding. It was shown that the 
more hydrophobic microcystin variants MC-LF and MC-LW clearly inhibited Caco-2 cell 
proliferation to a larger extent than MC-LR. The proportion of metabolically active cells diminished 
considerably, measured by formazan cleavage after treatment of 10 µM of MC-LF and MC-LW. 
Metabolically active cells are able to cleave WST-1 and the amount of formazan measured can be 
directly correlated to healthy cells. The obvious effect caused by MC-LW and MC-LF is in 
agreement with previous results, where it was concluded that the more hydrophobic microcystin 
variants were clearly more toxic than MC-LR in vitro and thus potentially also in vivo (Monks et al., 
2007; Fischer et al., 2010).  
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Figure 19. Caco-2 cell proliferation, assayed by the WST-1 test.  Cells were exposed to 1 µM, 10 µM 
and 50 µM of MC-LR (―), MC-LW (---) and MC-LF (∙∙∙). On the y-axis is the % absorbance of the 
amount of formazan dye formed which correlates to metabolically active cells, compared to control 
cells. Values are mean ± standard deviation of four wells each. Data shown is representative of 3 
individually performed experiments.  
 
4.4 PROTEIN PHOSPHATASE INHIBITION (V) 
MC-LR, MC-LW and MC-LF were compared with respect to their capacity to inhibit PP1A.  All three 
toxins inhibited protein phosphatase PP1A, MC-LF and MC-LW to a lesser extent than MC-LR. The 
normalized relative IC50 values calculated were 3.0 for MC-LF and 3.8 for MC-LW, compared to 1.0 
for MC-LR. MC-LR appears to be the strongest inhibitor of the phosphatases among the studied 
microcystins (Eriksson et al., 1990; Monks et al., 2007; Fischer et al., 2010). In this study the 
protein phosphatase inhibition capacity and the acute toxicity did not correlate with each other. 
The more hydrophobic variants were weaker protein phosphatase inhibitors but showed more 
pronounced cytotoxic effects against Caco-2 cells (Fig. 18 and 19). Other mechanisms besides 
inhibition of protein phosphatases, as well as differences in uptake, transport, detoxification or 
targets, have been suggested to modulate the toxicity of different microcystin variants (Blom and 
Juttner, 2005).  
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5 CONCLUSIONS 
Mass occurrences of toxic cyanobacteria limit the use of water for the purposes of drinking water 
production, recreation and fishing. Microcystins, common toxins produced by cyanobacteria, have 
documented adverse effects on human health, ranging from mild dermatitis to death. This PhD 
thesis contributed to risk assessment of microcystins. 
a) Development of immunoanalytical methods and analyses of environmental samples 
As the microcystin concentrations in environmental waters are highly unpredictable it is important 
that fast, convenient and sensitive analytical methods for the detection of microcystins are 
available.  
In paper I, a time-resolved fluoroimmunoassay, TR-FIA, was developed. In an attempt to increase 
the sensitivity of immunoassays, time-resolved fluorescence was used as the detection method.  
To avoid steric problems in the recognition of antigens by their antibodies a relatively small label, 
europium, was coupled to MC-LR. Lanthanide chelates show a longlived fluorescence which made 
it possible to efficiently avoid interfering background fluorescence. Moreover, the large Stokes 
shift and the narrow emission enabled the fluorescent signal to be measured with high specificity. 
TR-FIA was shown to have a lower detection limit compared to ELISA as the detection limit was 
determined to 100 pg/l. That implies a broader dynamic range for TR-FIA. 
In paper II and III, the developed immunoassay, TR-FIA, and a commercially available ELISA were 
used for screening of waterbodies on Åland Islands, SW Finland. The immunoassays were 
compared to chromatographic techniques and protein phosphatase inhibition assay in the 
detection of microcystin. Both immunoassays were shown to be sensitive, reliable and practical 
analytical methods for direct measurement of microcystins in field samples, without need to 
concentrate the samples. Microcystins were detected in roughly 10% of the studied lakes. The 
highest microcystin concentration was 30 µg/l (according to ELISA). 
The development of immunoanalytical methods as well as the analyses of environmental samples 
generated tools, insight and data for exposure assessment which is an integral part of the risk 
assessment of microcystins. 
b) Characterization of more hydrophobic microcystin variants 
Several countries have adopted the WHO guideline value of 1 µg MC-LR per litre drinking water. 
The guideline value is based on data available from e.g. hazard and dose-response assessments. 
However, the data available is limited and many toxicity studies are based either on one common 
variant, MC-LR, or on cell extract preparations containing multiple toxins. The toxicity of 
microcystins varies greatly, and in this thesis focus was put on the more hydrophobic variants, MC-
LF and MC-LW, in order to complement the numerous toxicological experiments conducted with 
MC-LR. 
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In paper IV and V interactions of MC-LR, MC-LW and MC-LF with artificial lipid membranes were 
studied to see whether the hydrophobicity of a microcystin has an effect on the lipid membrane. 
The relatively hydrophobic microcystin variant studied, MC-LF, showed the highest surface activity 
potential with the surface barostat technique used, closely followed by MC-LW. It was concluded 
that the more hydrophobic microcystins were clearly more surface active compared to MC-LR. 
Moreover, the fluorescence emission profile of MC-LW was shifted when interacting with vesicles. 
It was concluded that MC-LW and MC-LF locate closer to the membrane-water interface compared 
to MC-LR. Although an association between the more hydrophobic microcystins and lipids seemed 
to exist, any spontaneous penetration of microcystins across a lipid membrane was not 
interpreted to occur.   
In paper V, the toxicities of three different microcystin variants were compared on Caco-2 cells. 
Apoptotic features deduced from morphological examination, with shrinking and blebbing of cells 
was most evident in MC-LF treated cells closely followed by MC-LW. Cytotoxicity, quantified by 
lactate dehydrogenase leakage, and cell proliferation and viability, assessed by mitochondrial 
dehydrogenases, showed obvious deteriorations when cells were exposed to MC-LF and MC-LW. 
Altogether, exposure to hydrophobic microcystins can result in different organotropism, 
toxicokinetics and bioaccumulation compared to that of e.g. microcystin-LR. 
The characterization of (more hydrophobic) microcystins contributed to both hazard identification 
and dose-response assessment. 
c) General statement concerning the overall risk caused by microcystins 
Microcystins were frequently found in the study area (Åland Island’s water environment) at 
concentrations which exceeded the WHO guideline level for microcystin-LR in drinking water. 
However, based on available research and knowledge it can be expected that modern drinking 
water treatment would in most cases reduce the detected microcystin concentrations to a safe 
level. None of the found microcystin concentrations were alarmingly high with regard to the 
recreational use of water. The prevalence of the potentially more harmful microcystins, i.e. the 
more hydrophobic variants, was very low according to the investigations reported in this PhD 
thesis. In the light of the presented results it can be concluded that the overall risk which 
microcystins constitute to the water users in the study area is fairly low as long as lake water is not 
directly used for drinking water, and mass occurrences of toxic cyanobacteria are avoided during 
recreational use of water. 
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